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ABSTRACT
The School of Graduate Studies
The University of Alabama in Huntsville
Degree

Master of Science

Name of Candidate
Title

Program

Modeling and Simulation.

James M. J. Lawlor.

Application of Machine Learning Models to CFTR Enhancer Discovery.
Cystic Fibrosis is a Mendelian genetic disorder causing production of hyper-

viscous mucus, which damages organs including the lungs and digestive system, and
is the result of absent or defective production of the chloride transport protein CFTR.
CFTR expression varies between organs, developmental stages, and individuals. We
develop and optimize a machine learning pipeline to identify enhancers—binding sites
for regulatory proteins—near CFTR. We segment A549, Caco-2, Calu-3, and PANC-1
genomes, train a sequence-based classifier on the predicted enhancer segments, and
use the classifier score to predict sequence variants’ enhancer activities. Our optimizations appreciably improve the resulting enhancer predictions. We present 112 highinterest variants for further analysis and observe a minority of CF-causing variants
predicted to modify enhancers. Our pipeline summarizes a vast amount of epigenetic
data into a robust and simple metric, yielding valuable functional hypotheses.
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People who deny the existence of dragons are often eaten by dragons. From within.
—Ursula K. Le Guin

CHAPTER 1

INTRODUCTION

This thesis describes our construction, optimization, and use of a machine
learning pipeline to describe and predict candidate regions of the human genome that
influence the expression of the Cystic Fibrosis Transmembrane Regulator (CFTR)
gene. A variety of mutations in the CFTR gene give rise to the genetic disease Cystic Fibrosis, which is characterized by persistent lung infections, poor digestion, and
progressive organ damage [Rowe et al., 2005]. Cystic Fibrosis affects over 70,000
people worldwide, including the author [Bobadilla et al., 2002]. Further characterization of the gene regulatory environment of CFTR will improve understanding of the
underlying pathology of the disease and may elucidate new avenues for treatment.
Each living cell contains a genome, the total heritable biological information
that can be passed on to new cells or new organisms, which in most organisms is
chemically encoded as a sequence of bases in deoxyribonucleic acid (DNA) macromolecules. Genes, as the discrete units of inheritance, are regions of these DNA
macromolecules that can be associated with a particular observable (phenotypic)
trait. Genes are expressed by the production of proteins (which carry out the majority of the cells’ metabolic functions) and other regulatory ribonucleic acids (RNA).
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For example, pathogenic mutations in the DNA code of the CFTR gene give rise
to absent or non-functional CFTR protein and, in individuals with two pathogenic
copies of CFTR, the disease phenotype of Cystic Fibrosis. Only a small fraction
(approximately 1%) of the human genome is protein-coding sequence; the non-coding
portions of the genome, which do not generate a particular protein or RNA product, often serve as regulatory regions. The regulation of genes—how much, if any,
of a given portion of coding DNA is expressed, and when the expression occurs during a cell’s lifetime—is a critical component that drives the differentiation of cells,
individuals, and species [Wittkopp and Kalay, 2012].
Gene expression is activated or deactivated by complex, dynamic, and nonlinear networks of regulatory molecules. In creating a protein from a DNA template,
the gene is first transcribed to a molecule of messenger RNA (mRNA) by the RNA
polymerase enzyme complex. Our research focuses on the regulatory elements that
interact with this initial step of the transcription process. A variety of DNA-binding
proteins attach to specific DNA sequences and control the expression of nearby genes
by either recruiting or blocking the RNA Polymerase complex. The DNA-binding
proteins themselves are products of other genes within the genome, and thus subject to similar up-regulation or down-regulation by other members of the network.
These regulatory sites are examples of a larger set of biochemical tools to regulate
gene expression. Interactions with intercellular and intracellular chemical messengers
allow for gene expression to change in response to a cell’s internal and external environments. Within the cell, DNA is organized into chromosomes: complexes of DNA
and structural proteins called histones. The winding of DNA around the histone
2

proteins is another means of regulating gene expression: chromatin structure controls
the physical access of the transcription machinery to the DNA, and its accessibility
may be altered by a variety of chemical modifications on the histone proteins.
Since the completion of the Human Genome Project and publication of the
human reference genome, significant focus has turned to identification and characterization of the different functional elements of the genome outside of the proteincoding regions. For example, the ENCODE Project is a large-scale, multi-institute
genomics database that incorporates evolutionary information, generated by comparative studies among species; genetic information, generated by direct observation
of the phenotypic results of DNA-sequence alteration; and biochemical information,
generated by cell-specific observations of chromatin structure, binding of regulatory
proteins, or chemical modification of the histone proteins [Kellis et al., 2014]. As
a result, the amount of genomic information has increased exponentially in the last
decade. The human genome is approximately 3.2 billion base-pairs long; it is easy
to see how integration of the results of dozens of types of experimental data across
hundreds of cell-types of interest quickly becomes a problem of computational complexity and dimensional explosion. As a result, advanced computational techniques
and machine learning models are an essential tool for condensing and interpreting genetic data. Both supervised and unsupervised statistical learning models are useful;
for example, supervised models can identify functional elements such as transcription start sites based on similarity to labeled training data; unsupervised models can
segment an entire genome into similar regions, which may identify novel functional
elements [ENCODE Project Consortium et al., 2012, Libbrecht and Noble, 2015].
3

The CFTR gene codes for an anion transport protein found at the apical
membrane of the epithelial cells lining the body’s mucous membranes. There, it
pumps chloride and bicarbonate outside of the cell, which osmotically regulates the
water content of the mucus secreted by these cells. Mutations in the CFTR gene lead
to reduced, absent, or impaired CFTR proteins on the cell surface. For example, the
most common mutation, F508del, causes the protein to fold improperly, then causing
the cell to degrade the CFTR before it can reach the cell surface. Without the proper
functioning of this channel, the protective mucus secreted by these cells is dehydrated,
becoming too thick and sticky. This viscous mucus is more difficult to clear from the
lungs, where it becomes a breeding ground for bacteria, leading to a cycle of frequent
lung infection, inflammation, and damage. In the digestive system, the mucus blocks
the digestive enzymes secreted by the pancreas, leading to chronic malabsorption of
nutrients. Diabetes, due to damage to the pancreas, and cirrhosis, due to obstruction
of the liver’s bile ducts, may also result [Rowe et al., 2005].
To date, the majority of treatments for Cystic Fibrosis focus on antibiotics
to fight chronic infections, inhaled medications and chest physiotherapy to thin and
remove mucus, replacement of digestive enzymes, and similar treatments that address
the many effects of the disease but not the root cause at the cellular level. However,
recently-approved and in-development treatments seek to directly repair CFTR function. CFTR correctors and CFTR potentiators, respectively, increase the amount
of CFTR transported to the cell membrane and increase its activation [Wainwright
et al., 2015].
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Cystic Fibrosis is observed to be a highly variable disease. The numerous types
of CFTR mutations are one significant source; for example, mutations that reduce
or eliminate CFTR at the cell surface (such as F508del) tend to lead to more severe
phenotypes than mutations that lessen CFTR function but not quantity. However,
even within a given genotype, there is significant variation in individual disease progression. Some variation can be explained by individual medical history (availability
of specialized care, adherence to treatments, acquisition of certain infections, etc.),
but much remains unknown [Knowles and Drumm, 2012]. Therefore, research that
helps elucidate the cellular mechanisms that control CFTR expression may help increase our understanding of the phenotypic variability in Cystic Fibrosis and suggest
mechanisms to improve our treatment of the disease. Currently, our examination of
variability in Cystic Fibrosis disease is focused at the transcriptional level; we seek to
understand how variation in the amount of mRNA transcribed from the CFTR gene
varies across individuals, interacts with CF-causing variants, and can be engineered
to treat the disease.

5

CHAPTER 2

BACKGROUND

2.1

Central Dogma

The central dogma of molecular biology states that heritable information is
encoded in deoxyribonucleic acid (DNA), located a eukaryotic cell’s nucleus, where
it is then transcribed by the enzyme RNA Polymerase into messenger ribonucleic
acid (mRNA); the mRNA exits the nucleus into the cytoplasm of the cell and is
translated by the ribosomes into functional protein products which carry out the cell’s
activities [Alberts et al., 2002]. We begin our examination of CFTR regulation by
reviewing the biochemical systems that regulate transcription and their implications
for the study of genomics.

2.1.1

Gene Regulation, Cis-Regulatory Elements, and Chromatin Marks
Gene expression is the creation of a functional molecule, such as protein, from

the template contained in the organism’s genome. The expression levels of genes
must be regulated to ensure proper cell function, including spatially (in different cell
types or different areas of an organism), temporally (at different phases of organism
development or the cellular lifecycle), and in response to an organism’s environment.
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Our research focuses on regulation at the point of transcription initiation, which
involves the complex interaction of plethora of DNA-binding proteins that increase or
inhibit the physical access of the RNA polymerase complex (the molecular machinery
that transcribes DNA into mRNA) to the gene locus. Expression is also regulated at
the subsequent steps in the expression process: splicing and processing of mRNA, and
translation of the mRNA into functional protein [Nestler and Hyman, 2002]; however,
these types of downstream regulation are beyond the scope of this research project.
Cis-regulatory elements (CREs) are the specific sequences of DNA that are
recognized and bound by DNA-binding proteins in order to increase or decrease the
expression of genes. Promoters, where RNA polymerase initially binds to begin transcription of a gene, are sequences that are necessary and sufficient to initiate (at
least low levels of) gene expression; promoters are highly conserved between species.
Promoters are a critical point of regulation, and their disruption easily reduces or
eliminates gene expression; as a result of this and their high interspecies conservation, promoters cannot be the primary cause of differential gene expression (and thus
phenotypic diversity). Instead, enhancer CREs are the primary source of diversity in
gene expression. Enhancers recruit complexes of DNA-binding proteins that encourage assembly and activation of the RNA polymerase complex at the promoter. While
promoters occur just upstream of a gene’s transcription start site, enhancers may be
found far upstream, downstream, or inside the introns of their target genes. Such
a long-distance interaction involves the creation and regulation of DNA looping and
other complex, three-dimensional structures. Enhancers do not act in isolation; in
fact, different sets of enhancers act on a given gene when compared across cell types
7

Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews Genetics [Shlyueva et al., 2014], copyright © 2014

Figure 2.1: CREs and Chromatin Accessibility [Shlyueva et al., 2014].

or stages of development [Wittkopp and Kalay, 2012]. Other CREs include silencers,
which are the functional opposites of enhancers; and insulators, which demarcate the
boundaries of an enhancer’s or a silencer’s effect [Li et al., 2015].
In the cell nucleus, DNA is coiled and compacted around histone proteins into
spool-like structures called nucleosomes. In order to be accessible to other DNAbinding proteins, the DNA must be unwound from the histone spool. Thus, the
histone structure directly affects the activity at cis-regulatory elements. Enhancers
may be active in open, loosely-coiled regions of DNA, but transcription factors are un-
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able to bind CREs that are coiled tightly into nucleosomes. Histones are also subject
to dozens of chemical modifications such as acetylation and methylation; the patterns
of the particular histone modifications are strongly associated with gene regulation
and the presence of CREs. For example, the modifications known as H3K4me1 and
H3K27ac often flank active enhancers. Figure 2.1 shows a representation of closed
vs. open chromatin and how the chromatin structure affects binding of regulatory
proteins to CREs. Enhancers also occur without histone modifications. It is important to note that the precise functional and mechanistic roles of histone modifications
(and whether they are a cause or effect of regulation) is still an open question; however, the distinct patterns can greatly enhance the characterization of a genomic
locus [Shlyueva et al., 2014].

2.1.2

Transcription Factors and Their Interactions
Transcription factors (TFs) are the DNA-binding proteins that bind to cis-

regulatory elements and, directly or indirectly, interact with the RNA polymerase
complex to regulate the expression of a target gene. A given transcription factor may
have a positive or negative regulatory effect. Positive regulation occurs by stimulation of the assembly RNA polymerase complex or by up-regulation of its activity.
Negative regulation can occur by direct inhibitory interaction with the RNA polymerase complex, or by interaction with other TFs. Transcription factors themselves
may be modified by protein modifications or by up-regulation or down-regulation of
the genes which encode them (making them trans-regulatory elements with respect
to the target genes) [Latchman, 1997].
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The mapping between associated transcription factors and cis-regulatory elements is important; a given TF will bind multiple, diverse CREs, and a given CRE
will be bound by multiple TFs. Furthermore, a single TF can only bind a small, 6-12
base-pair (bp) long segment of DNA, leading to many opportunities for incidental TF
binding outside of an active CRE. As a result, the gene regulation activity of a TF and
CRE pair must be more complex than presence of the TF bound to DNA [Shlyueva
et al., 2014]. While some enhancers can be shown to be occupied continuously by
TFs, many enhancers demonstrate varying occupancy across developmental stages or
cell types. In addition to their role regulating the promoter, TFs may interact with
other TF/CRE pairs by jointly binding common co-factors, encouraging re-modeling
of chromatin (activating or de-activating other enhancers), or altering the long-range
3-dimensional DNA interactions [Spitz and Furlong, 2012].
Interactions between transcription factors suggest that the organization of
their DNA-binding motifs within enhancers, i.e. the enhancer’s motif grammar, are
essential for the enhancer’s regulatory function. The motif grammar positions the TFs
to properly interact with each other, necessary co-factors, and the RNA polymerase
complex. Highly-cooperative complexes lead to switch-like control of the target genes,
while more loosely-organized motif grammars may function in an additive fashion,
allowing for a gradient of control of the target genes [Spitz and Furlong, 2012]. For
example, the glucocorticoid receptor has been shown to function as an “enhancer
cluster” which require the cooperation of multiple CREs and TFs to coordinate the
gene regulatory response to the glucocorticoid hormones [Vockley et al., 2016].
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2.2

CFTR Expression

Table 2.1: CFTR Expression in Relevant Tissues
Tissue

Median RPKM Mean RPKM Standard Deviation Coefficient of Variation

Colon Transverse
13.158
Lung
1.339
Minor Salivary Gland
5.348
Pancreas
45.295
Small Intestine Terminal Ileum 3.503

12.024
1.661
7.157
49.32
3.887

9.437
1.473
5.968
17.208
2.469

0.785
0.887
0.834
0.349
0.635

Expression of the CFTR gene varies significantly between tissues, individuals,
and stages of development. Prior to this project, our lab member Edelloyd Garcia analyzed the expression of CFTR across several CF-relevant tissue types. We obtained
RNA expression data for 544 individuals and 53 tissue types from the GenotypeTissue Expression (GTEx) Project [GTEx Consortium, 2013]. We calculated summary statistics on CFTR expression for all tissues having greater than 1.0 reads per
kilobase of transcript per million mapped reads (RPKM); Table 2.1 shows the resulting statistics, which demonstrate that CFTR expression varies significantly between
tissue types and across individuals. Figure 2.2, Figure 2.3, Figure 2.4, Figure 2.5, and
Figure 2.6 are violin plots comparing the distributions of CFTR expression among
samples in these tissues; with the exception of the colon, which is left-skewed, we
observe that all are right-skewed and clearly non-normal by visual inspection. The
per-individual variance is punctuated by high-expressing or low-expressing outliers.
In terms of development, CFTR is much more highly-expressed in embryonic and
fetal tissues than adult tissues; this development is known to be regulated in part
by lung-specific transcription factors [Viart et al., 2015]. (It is important to note
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Figure 2.2: GTEx CFTR Expression: Colon

that Viart et al. demonstrate significant post-transcriptional regulation of CFTR by
microRNA, which is outside the scope of our current study.)

2.3

Simplifying ChIP-seq Data with Hidden Markov Models & Genome
Segmentation with IDEAS

After the sequencing of the human genome, the Encyclopedia of DNA Elements (ENCODE) project began to explore the functional implications of the newly-
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Figure 2.3: GTEx CFTR Expression: Lung

discovered sequences by generating thousands of datasets from various biochemical
and sequencing assays designed to measure signatures of transcription, regulation,
and other biological activity associated with the genome. These data have generated a wealth of insights which have transformed our understanding of genomics
and molecular biology; however, drawing inferences from these vast datasets requires
automated tools to extract patterns and reduce the dimensionality of the data to a
human-interpretable size [ENCODE Project Consortium et al., 2012]. Hidden Markov
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Figure 2.4: GTEx CFTR Expression: Pancreas

Models, which we review below, are a popular and well-studied method used to perform such large-scale integrations of ENCODE data.

2.3.1

Chromatin Immunoprecipitation Sequencing & DNase-seq Data
Chromatin immunoprecipitation and sequencing (ChIP-seq) characterizes the

landscape of chromatin and transcription factors bound to a cell’s genome [Johnson
et al., 2007]. Histone and other DNA/protein complexes are chemically fixed to
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Figure 2.5: GTEx CFTR Expression: Small Intestine

produce a snapshot of the interactions. DNA is fragmented and antibodies to a target
protein feature (such as an individual TF or histone modification) are used to select
DNA fragments for sequencing. Sequence data are processed to produce a density map
of the target protein’s binding across the genome. Similarly, in DNase I hypersensitive
sites sequencing (DNase-seq), enzymes are used to cut DNA at accessible (nucleosomefree) regions, which can then be sequenced to identify which regions of the genome
are accessible to DNA-binding proteins. Distinct data are available for dozens of TFs
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Figure 2.6: GTEx CFTR Expression: Salivary Gland

and histone tags in multiple cell types. Thus, discovery of enhancers and regulatory
elements requires integrating and discovering patterns within multiple, extremely
large datasets [ENCODE Project Consortium et al., 2012, Ernst et al., 2011, Myers
et al., 2011]. Figure 2.7 shows an example of several ChIP-seq and DNase-seq data.
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Copyright: © 2011 The ENCODE Project Consortium.
Reproduced with permission under the terms of the Creative Commons Attribution License.

Figure 2.7: Example ChIP-seq and DNASE-seq data [Myers et al., 2011].

2.3.2

Hidden Markov Models
Hidden Markov Models (HMMs) analyze observed spatial or temporal pat-

terns, such as genomic sequences, by assuming an underlying, un-observed (hidden)
set of states [Baum and Petrie, 1966]. HMMs may be used as unsupervised models, which do not require the training data to be labeled with an assumed pattern.
HMMs are governed by two stochastic parameter sets: the set of emission probabilities, which generate the observed outputs based on each hidden state; and the set
of transition probabilities, which generate the state at each position based on the
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previous position’s state. In order to develop the HMM, an ideal set of hidden states
and their sequence must be estimated and optimized, for example, to have the most
likely individual states (posterior decoding), or to have the most likely best path state
sequence (the Viterbi algorithm). During model training, the HMM transition and
emission parameters are optimized to maximize the likelihood of the observed data
given the model. Given the transition parameters and emission parameters, the likelihood of an observed pattern may be computed from the HMM, allowing selection of
the best model and scoring of newly-observed patterns; to make this computationally
tractable, the probability calculation is divided into a forward-looking and backwardlooking partial sequences of observations, which may be calculated recursively then
re-combined into the joint probability [Rabiner and Juang, 1986].
A HMM models the evolution of some discrete or continuous signal across the
unidirectional evolution of a single, discrete variable (i.e., across a discrete time scale
or in a single direction through space) via the interaction of two stochastic processes.
For example, a HMM could model a discretized sound signal for speech recognition,
a biochemical signal across a set of genomic coordinates, or the outcome of a set of
conceptual experiments: drawing colored marbles from a set of urns, each with a
different proportion of colors. The first, “hidden” stochastic process is a function of
time (or space) and represents the un-observable state: a phoneme, a component of a
gene, or a particular urn. The bridge between the hidden process and the data that
may be observed is a second stochastic process which generates, based on the state,
an output signal: a noisy sound wave, a measure of the amount of RNA Polymerase
bound to DNA, or a colored marble. In general, we are interested in obtaining the
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state sequence that makes up the hidden layer, which will provide knowledge to help
interpret our data: the words spoken, the location of genes, or the marble-picker’s
favorite urns [Rabiner and Juang, 1986, Fink, 2014].
HMMs rely on two assumptions regarding the interdependencies of the stochastic properties: the Markov property, that a state is determined based only on the prior
state; and the output independence assumption, that the output signal is determined
based only on the current state of the model. As a result, the classic HMM may be
completely defined by a set of states and their associated output-generating probability distributions (the emission distributions); the transition matrix, which stores the
probabilities of transitioning between each pair of states; and a vector of probabilities
for picking the starting state [Rabiner and Juang, 1986, Fink, 2014].
Rabiner and Juang frame HMMs in terms of three central problems, for each of
which exist a choice of solutions that vary in optimality, complexity, and suitability for
different use cases. In general, the primary computational tasks with regard to HMMs
are decoding, determination of best state sequence; evaluation, determination of the
probability of a given observation sequence; and training, determination of the set of
parameters (transition matrix, emission distributions, and initial state probabilities)
that best describe the real-life observational data [Rabiner and Juang, 1986].
Classically, the HMM is defined for a finite set of states; as a result, even
when using a HMM in an unsupervised fashion, it is necessary to begin the algorithm
having an initial guess of the state transition matrix and state emission distributions.
In the case of genome segmentation, where a large part of the modeling motivation
may be to discover previously unknown states or decipher a previously unexplained
19

combination of biochemical observations, this situation is far from ideal. This limitation may be addressed with the infinite-state HMM (iHMM). In an iHMM, instead of
representing transition probabilities from a given state with a static row of a matrix,
the transition matrix can grow as the the model proceeds and each row of the transition matrix is itself probabilistically defined. For a given transition, the model first
chooses between no-transition (remaining in the current state), re-use of a transition
that was made in the past, or generation of a new transition. When generating a new
transition, the model chooses between using an existing state or generating a new
state (which requires widening the transition matrix). This framework expands the
task at generating a state transition from “draw a state from a distribution defined
by a row in the transition matrix” to “draw a distribution for a row in the transition matrix from a distribution-of-distributions”; this meta-distribution is called a
Dirichlet process. Conceptually, the Dirichlet process can be thought of as a bag of
mixed dice of varying sizes: first, one draws a die from the bag (random selection of
a distribution), then rolls the die to obtain a number, with the overall distribution of
numbers now controlled both by the properties of the individual dice and the mixture
of dice within the bag [W. Freeman, personal communication, May 12, 2017]. Use of
an iHMM-containing model for genome segmentation allows specification of a prior
expectation of resulting genomic states, which may then vary depending upon the
data, instead of specification of a precise limit [Beal et al., 2002].
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2.3.3

Genome Segmentation with IDEAS
Hidden Markov Models form the basis of several genome segmentation tools,

which use observations such as histone modifications and DNA accessibility to predict
the underlying hidden pattern of genomic regions (exons, promoters, enhancers, insulators, etc.). Semantics are assigned to the resulting state pattern based on empirical
data from well-characterized regions of the genome. These models often provide information at the nucleosome scale (approximately 200bp) [Day et al., 2007,Ernst and
Kellis, 2012, Zhang et al., 2016].
Early HMM-based genome segmentation tools were designed to segment a
single genome. However, chromatin profiles exist for numerous cell-types, and it is
well established that both chromatin profiles and gene regulation vary significantly
between cell-types. Multiple genomes may be concatenated and scored jointly with
stacking or concatenation; unfortunately, concatenation neglects the broad-scale positional information, and stacking neglects the cell-type-specific information. Zhang
et al.

developed the Integrated and Discriminative Epigenome Annotation Sys-

tem (IDEAS), which uses multiple HMMs to jointly model the features of multiple
genomes. This allows information to be shared across similar cell types as Bayesian
priors, increasing the confidence and consistency of the resulting segmentation [Zhang
et al., 2016].
To begin a conceptual overview of IDEAS, consider the training data: for
each of several cell types, a discrete set of genomic coordinates and a corresponding
matrix of observations of many types of epigenetic data (such as the intensity of a
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histone mark signal). These signals may be represented as a mixture distribution, in
this case summarized by an infinite-dimension vector holding weights of multivariate
normal distributions, which act as basis functions. Zhang et al. call the weighting
vector πijk , as there will be one per combination of cell type i, genomic position
j, and epigenetic state k. Next, πijk is modeled as a Dirichlet process across all
states k; each random draw from this Dirichlet process will return a distribution
that will be used as the emission distribution to model the observed distribution
generated by a given state. A set of iHMMs is constructed: one for each cell type
in the model plus one to represent the generic, cell-type-non-specific features per
position. The hidden state of the cell-type iHMMs represents the membership in a
cluster of locally-similar cell types, while the hidden state of the additional iHMM
represents a position classification and summarizes the typical expectation for an
observed epigenetic signal at that location. Then πijk is defined as a function of the
hidden states of the iHMMs; to put a finite bound on its size and sample space, πijk
is restricted so that it returns the same information if two cell types belong to the
same cluster at a given position j and so that the prior distribution of πijk at each
position is defined by position classifying iHMM’s hidden state. As the probabilities
governing each of the HMMs and the Dirichlet process are combined into one unified
joint distribution, πijk then acts as the emission distribution for all iHMMs, and
allows each to optimized to best fit the observed training data. To execute the model,
initial values of the distributions are arbitrarily assigned or sampled from the training
data and the resulting probabilities from model are calculated using a Monte Carlo
method. The probabilities are used to update the iHMM parameters and Dirichlet
22

parameters and finally the model is iteratively re-calculated and re-updated until it
best matches the training data. Figure 2.8 shows an overview of the IDEAS concept
and a schematic of the model hierarchy and dependencies; π is as defined above,
α represents the prior distribution of π, S represents the cell and position-specific
clustering, and x represents the observed epigenetic data [Zhang et al., 2016].
IDEAS claims a number of advantages over similar methods that use HMMs
to perform segmentation according to epigenetic data such as chromatin marks. Most
importantly, IDEAS retains and uses both the positional information and the celltype-specific information that can be lost when datasets are stacked or concatenated;
we want to use positional information to maintain consistency across segmentations
(e.g., having a constitutively active gene transcription region in once cell, but a permanently repressed intergenic region at the same location in another cell would be
suspicious), while using the cell similarity relationships to better distinguish a unique
epigenetic pattern that could otherwise be considered noise. Additionally, unlike
some of the other cell-type-specific segmentation tools, IDEAS does not require input
information delineating the cell-type clusters, as it is able to learn these features from
the data [Zhang et al., 2016].

2.4

Uncovering Principles of Gene Regulation Through Motif Analysis
With gkm-SVM

The large-scale functional predictions generated by segmentation tools can
provide a wealth of biological insight; however, in order to complete our understanding of gene regulatory networks, such as those acting upon CFTR, we require the
23

Zhang, Yu; An, Lin., Jointly characterizing epigenetic dynamics across multiple human cell types., Nucleic Acids Research, 2016, 44, 14, 6721-6731, by permission of Oxford University Press

Figure 2.8: IDEAS Overview and Schematic [Zhang et al., 2016].

ability to generate actionable hypotheses at the sequence level. For example, complete characterization of an enhancer element would require characterization of the
particular sequence motifs leading to TF binding, in order to identify the TFs and
associated regulatory networks involved. Below, we review theory and application of
Support Vector Machines that can support such an investigation.

2.4.1

Support Vector Machines
Support Vector Machines (SVMs) are supervised, binary classifiers that de-

termine a hyperplane to separate the positive and negative training data with the
24

Copyright © 2004 The MIT Press. Reprinted by permission.

Figure 2.9: Schematic of a maximum-margin linear classifier [Vert et al., 2004].

maximum margin; i.e., maximum distance between the dividing hyperplane and the
nearest data points in each set. These data closest to the margin are the support
vectors, as the hyperplane may be described as a weighted sum of these vectors.
Non-linearly-separable data may be transformed with a variety of kernel functions,
which compute a measure of similarity between any two data points, eliminating the
need to explicitly transform the entire dataset into a higher-dimensional space. The
model is calculated iteratively: a subset of input data is used to build a boundary and
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score other subsets; then, points that lie close to the boundary are added as support
vectors to refine the next iteration [Boser et al., 1992].
To summarize the construction of a SVM, consider the problem of finding
a linear classifier, i.e. a line to separate two clusters of labeled points in a twodimensional plane. This problem may be generalized to finding a (n − 1)-dimensional
hyperplane to separate two clusters of points in an n-dimensional space. When the
data are linearly separable, we may find a multitude of hyperplanes to separate the
under the constraint that no points may be misclassified. In order to find a unique
(and more robust) solution, we instead insist that the dividing hyperplane have the
maximum margin, i.e., that we will maximize the distance between the dividing
hyperplane and the nearest points on either side. Through straightforward geometric
reasoning, the authors demonstrate that this reduces to the problem of finding an ndimensional weighting vector with minimum length, as the margin width is inversely
proportional to the norm of the weighting vector, subject to the constraint that all
points fall on or beyond the margins (on the correct side). Those points that fall
directly on the margin lines, which lie parallel to the classification boundary in the
middle, are termed the support vectors. Figure 2.9 shows a schematic of the linear
classifier with maximum margin. Classification of a data point is calculated via dot
product with the weighting vector, i.e. f (x) = w·x+b with the classification margins
at f (x) ≥ 1 and f (x) ≤ −1 [Vert et al., 2004, Boser et al., 1992].
In order for the above algorithm to be applicable to a wide range of real-world
problems, it must account for the possibility that the data may not be completely
linearly separable. The next adjustment the SVM makes to a simple linear classifier
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is to allow for the possibility of an unconfidently-classified (within the margin area)
or misclassified data point by introducing a hinge loss function, which is equal to zero
when a data point is correctly classified and increases linearly as it moves further from
the correct side of the margin. Now, the correct-classification constraint is removed
and the target for minimization is the norm of the weighting vector plus the total hinge
loss (i.e. we are minimizing the maximum loss); an additional parameter, sometimes
called the SVM-C parameter, is included to weight the hinge loss in the minimization
target, allowing adjustment of the model’s sensitivity to misclassification [Vert et al.,
2004, Boser et al., 1992].
This minimization problem can be solved via the method of Lagrange multipliers, the details of which are significantly out of scope for our examination; however,
two particularly important observations result from the transformed classification
function f (x) =

Pn

i=1

yi αi xTi x + b, where (xi , yi ) are the labeled training data and αi

are the Lagrange multipliers resulting from the optimization. First, it can be shown
that the Lagrange multiplier αi = 0 if xi lies outside the classifier’s margins, i.e. if
|f (x)| > 1; this means that the classifier is defined only by the points that lie on or
within the margins of the decision boundary, i.e. the support vectors. Second, the
classification of any new data point can be made by comparison (via the dot product, xTi x) with each of the support vectors, instead of by comparison with a vector
representing the complete solution (i.e. w) [Vert et al., 2004, Boser et al., 1992].
The reduction of the classification problem to a comparison operation (the dot
product xTi x) with a subset of the training data (the support vectors) is a particularly
important result, because it suggests that the dot product may be replaced by an
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arbitrary kernel function. A kernel function maps two arbitrary objects of the same
type to a real number (with the stipulations that the function must be symmetric
and positive semidefinite); it can be shown that any kernel function is equivalent to
the dot product in another coordinate space (specifically, a Hilbert space). That is
to say that evaluating a kernel function on two objects is equivalent to performing
a transformation on each object and then calculating the dot product on the two
vectors resulting from the transformation—but all without the need to explicitly
calculate the transformation. Figure 2.10 depicts a visual schematic of this kernel
trick, showing concentric circles of points which are not linearly separable in a plane,
but become separable after projection to a higher-dimensional space [Baudat and
Anouar, 2001]. Use of a kernel function to generate a comparison between two objects
not only saves computation, but allows the SVM algorithm to be decoupled from
the representation of the data. As a result, the SVM allows a nonlinear decision
rule to be learned from the input data by the selection of an appropriate kernel,
because it is equivalent to re-mapping all of the data to a higher-dimensional space
where it is linearly separable and then performing the linear separation algorithm.
For example, the popular Radial Basis Function (RBF) kernel essentially builds the
decision boundary in terms of Gaussian functions, which allows classification of highly
nonlinear data, since the decision boundary may then take on a number of complex
shapes [Vert et al., 2004, Boser et al., 1992].
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Figure 2.10: Example of the kernel trick [Baudat and Anouar, 2001].

2.4.2

Motif Analysis With Gapped K-mer SVM (gkm-SVM)
SVMs may be used to identify functional genomic sequence elements by taking

frequencies of short DNA patterns (k-mers, DNA sequences of length k) occurring in
a larger sequence as the features of the training data. (For example, if k = 3, the
64-dimensional feature vectors are the frequencies of all possible 3bp sequences.) This
models the individual TF binding sites that make up enhancers or other regulatory regions. LS-GKM is an implementation of a k-mer-based SVM which modifies a string-
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comparison kernel to allow for gaps, i.e., the kernel is parameterized based on total
word length and number of informative positions. This estimates the true frequency
of longer strings, which may only be observed rarely in the training data [Ghandi
et al., 2014, Lee, 2016, Lee et al., 2011].
The genesis of this method traces back to the spectrum kernel [Leslie et al.,
2002], developed originally for classification of proteins by primary amino acid sequence; this kernel operates on sequences of a finite length from a defined alphabet
and is defined by the transformation of a string into a set of counts of substrings of a
defined length (k). For a simplified example, consider the four-letter alphabet of DNA
bases, {A, G, T, C} and substrings of length k = 3. The string “GATATA” contains 1
“GAT”, 2 “ATA”, and 1 “TAT”, and none of the remaining of the 64 possible 3-mers,
resulting in a particularly sparse vector in the feature space; the dot product in this
space is then a measurement of how many fixed-length substrings are shared between
any two strings. The kernel value may be rapidly calculated by storing counts of
observed substrings into tree data structures–a significantly more tractable approach
than manipulating exceptionally large and sparse vectors in a 4k -dimensional space.
Lee et al. then developed K-mer SVM, demonstrating that this kernel performed well
inside a SVM framework to identify and predict mouse enhancers bound by specific
transcription factors by learning k-mer patterns from ChIP-seq data [Lee et al., 2011].
Because TFs physically bind approximately 6-20 bp, longer k-mers ought to
be more informative due to their ability to fully span a binding site; however, this is
not the case for the original K-Mer SMV method: as sequences become longer, the
probability of observing that exact sequence within a region drops precipitously, and
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the resulting k-mer-count-space feature vectors become even more sparse (or empty).
Biologically speaking, TF binding affinity is not necessarily uniform across all bases
the protein will bind, which allows for an amount of degeneracy within the recognized
sequences. Ghandi and Lee et al. demonstrate that this can be modeled with gapped
k-mers, which have one or more non-informative positions within the full sequence,
e.g. AT AC ATG or A T CGATG instead of the full sequence (now called an “l-mer,”
with k informative positions when gaps are present) ATTACGATG. Now the featurespace vector is a count of all possible gapped k-mers; again, direct calculation within
this feature space is intractable, as it is of significantly higher dimensionality than
the original k-mer count feature space; however, they note that only a small subset of
possible gapped k-mers could be derived from any given observed l-mer and contribute
to the resulting feature-space dot product. Furthermore, they demonstrate that this
dot product can then be reduced to a function of only the mismatches between the two
observed l-mers, and represented as a sum across all possible numbers of mismatches
(m = 0 to l) of the observed count of l-mers with m mismatches weighted by another
function derived from the mismatch count. As a result, the gapped k-mer kernel
function can be computed via the “mismatch profile” of the l-mers within the input
sequences. Required computation can be decreased by limiting the sum to a lower
number of mismatches than (l − k), leading to a set of three parameters that control
how the gapped k-mers model sequence length (in LSGKM notation: total sequence
length, L; informative positions, K; maximum considered mismatches D) [Ghandi
et al., 2014].
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This gapped k-mer kernel may be used as-is in a SVM; however, Ghandi et
al. prefer instead to use the observed gapped k-mer frequencies to estimate the corresponding frequencies of the un-observed l-mers most likely to generate the gapped
k-mer observations, which leads to a non-zero frequency for all l-mers inside of a
given sequence. This is accomplished by weighting each gapped k-mer frequency observation by a function of the number of gaps and mismatches between the k-mer
and the corresponding l-mer. By examining the mapping between all possible l-mers
and gapped k-mers, they also show that the estimated frequency of all l-mers may
be calculated directly from the mismatch profile of the observed l-mers, without an
explicit construction of the gapped k-mer intermediates. This is referred to as the
“full gkm-filter,” or the“truncated gkm-filter” if the resulting frequencies are required
to be positive. This resulting kernel based on estimated l-mer frequencies may then
directly replace the original K-mer SVM kernel, and is referred to as the GKM kernel.
Ghandi et al. demonstrate significantly improved performance of gkm-SVM in comparison to the original K-mer SVM–particularly in the case of learning longer motif
lengths.

2.5

Variant Analysis With DeltaSVM

Compared to the human genome reference sequence, a typical Caucasian genome
carries on the order of 3 million single-nucleotide variants (SNVs) and 0.5 million insertion or deletion (indels) events [Shen et al., 2013], a vst number of which are rare
or unique compared to the population at large; as a result, methods to predict the
potential biological impact of a variant are increasingly important as we sequence
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more individuals. Functional predictions regarding DNA variants may focus on a
variety of details, such as consequence to the protein sequence [McLaren et al., 2016];
likely impacts of those protein changes [Adzhubei et al., 2010]; or measures of deleteriousness or propensity to be disease-causing [Kircher et al., 2014], to name a few.
Extending their gkm-SVM framework, Lee et al. also developed a variant scoring
model, DeltaSVM. The gapped k-mer SVM framework is designed to score a single
defined sequence, and has been most often applied to the reference human genome
sequence in order to draw highly general conclusions; in order to predict the impact
of a particular variant, the DeltaSVM model makes a comparison between a reference
sequence and an alternate sequence (hence the name). Specifically, DeltaSVM calculates the difference between the reference and alternate k-mer weights for all k-mers
that include the variant base or bases. Figure 2.11 provides an example. This allows
the DeltaSVM score to account for the potential for a variant to affect multiple binding sites in multiple ways; i.e., it not only considers whether or not a variant disrupts
a particular known DNA binding motif, but whether or not a new binding motif may
have been created or an extant binding motif strengthened. As the DeltaSVM model
is based on a particular set of gkm-SVM k-mer weights, it is highly customizable to a
given application depending on the source data used to train the gapped k-mer model.
Lee et al. provide several use-cases of DeltaSVM and demonstrate it’s effectiveness
in predicting biological effects such as enhancer activity [Lee et al., 2015].
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Reprinted by permission from Macmillan Publishers Ltd: Nature Genetics [Lee et al., 2015], copyright © 2015

Figure 2.11: Overview of the DeltaSVM model [Lee et al., 2015].
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CHAPTER 3

SURVEY OF THE LITERATURE

3.1

A Training Algorithm for Optimal Margin Classifiers

This paper provides the original description of the Support Vector Machine
(SVM) algorithm, here called the Optimal Margin Classifier, which underlies the
LSGKM model we implement. The SVM identifies the “supporting patterns” that
define the widest boundary between the positive and negative training sets. The
classification model is built iteratively, calculating the maximum margin boundary
for a subset of the data and then progressively adding support vectors from further
subsets if they fall close to the decision boundary. A variety of kernel functions aid
computation and increase flexibility by allowing a broad choice of comparison options
between vectors. As the SVM method produces a weight for each of the support
vectors defining the boundary and focuses on minimizing the maximum error, it is
particularly robust to outliers in comparison to methods that minimize a total-cost
function such as the least-squares error. Furthermore, the SVM is particularly useful
in that it summarizes the classification task in terms of a small subset of the total
training dataset, meaning that further classification efforts require comparisons only
with the support vectors, as opposed to comparisons with each of the training data.
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Outliers may easily be ranked by weight and automatically or manually removed from
the model in order to increase the classification margin [Boser et al., 1992].

3.2

An integrated encyclopedia of DNA elements in the human genome

The ENCODE project represents a large-scale, multi-center effort that assigned functional roles to 80% of the human genome. This was accomplished by integration of a variety of biochemical and sequencing assays (including ChIP-seq, Dnaseseq, and RNA-seq), which describe chromatin structure and modification, DNA modification, and gene expression. As these assays are generated on a variety of cell lines,
ENCODE data reveal the significant variation of these characteristics between cell
types and species. The ENCODE project spans the entire cycle of functional genomic
investigation, from the systematic and standardized generation of fundamental data,
to the development and use of computational tools to integrate datasets and draw statistical conclusions, to the application of those conclusions to refine our fundamental
understanding of biology and develop new investigational methods. The assay results
are publicly available and are included in the input data of genome segmentation
tools such as IDEAS and ChromHMM [ENCODE Project Consortium et al., 2012].

3.3

Architectural proteins CTCF and cohesin have distinct roles in modulating the higher order structure and expression of the CFTR locus.

The authors examine the effects of knockdown of two structural-regulation
proteins, CTCF and cohesin, on the expression of CFTR. CTCF binds to insulator
CREs, which localize the effects of enhancers to a particular genomic region; cohesin
36

binds DNA to create and maintain 3-D structures that bring enhancers into contact
with their target promoters. Depletion of CTCF and cohesin activity alters the 3-D
structure and TF-binding occupancies around CFTR, increasing its expression by
allowing promoter-enhancer interactions that are otherwise disrupted by insulators.
This supports the overall hypothesis that CFTR enhancers can be manipulated to increase expression; furthermore, the authors implicate the CTCF-mediated regulation
of the local interaction landscape as a driver of the highly cell-type-specific expression of CFTR and its neighboring genes, which have expression profiles significantly
different than CFTR [Gosalia et al., 2014].

3.4

A unified encyclopedia of human functional DNA elements through
fully automated annotation of 164 human cell types.

The authors present a novel method to assign semantics to integer-labeled
genome segmentations, devise a conservation-based score to assess the functional importance of each state resulting from a genome segmentation, and use the consensus of
these functionality scores across cell types to build a set of genomic regions predicted
to have significant functional importance. The current state of genomic segmentation
tools is reviewed in brief, and the authors note typical difficulties such as the tradeoffs required to integrate data across cell-types or the semi-automated nature of the
process, which requires a manual curation step to assign semantics to integer-labeled
genomic states. To address these issues, the authors suggest a fully-automated process with an additional machine learning step, in which a decision tree classifier is
trained on a set of previously-generated segmentations (ChromHMM, Segway, etc.)
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using label enrichment in known genes and average value of key chromatin modification features as features. To assess the importance of the resulting states, the
authors calculate a functionality score based on the upper-quartile conservation score
of the labeled genomic positions. This paper will provide a focal point for future
exploration of our project, allowing automated IDEAS state interpretation and a
potential orthogonal comparison for our gkm-SVM and deltaSVM scores [Libbrecht
et al., 2016].

3.5

ChromHMM: automating chromatin-state discovery and characterization

ChromHMM is a genome segmentation tool that predates the IDEAS model.
Similarly, ChromHMM also trains a HMM to identify genome function regions based
on chromatin modification (ChIP-seq) annotations. Unlike IDEAS, ChromHMM fully
discretizes the input data, converting the measurements at each genomic site to a
vector of binary observations, and trains a single independent model at a time. This
results in a conceptually and computationally approachable model, though it requires
users to either stack or concatenate data in order to model data across multiple celltypes [Ernst and Kellis, 2012].

3.6

Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves : A Nonparametric Approach

The authors present a method to determine the statistical significance between
the areas underneath Receiver Operating Characteristic curves (AUROC) that are
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derived from the same validation dataset. When two models are trained and crossvalidated on the same set of data, a natural correlation is introduced into the AUROC
measurement as a result of the shared identity of the positive and negative validation
samples. The DeLong test uses the properties of AUROC as a Mann-Whitney Ustatistic to derive a non-parametric measurement of this correlation, which allows
for the derivation of the covariance matrix required to generate a confidence interval
and statistical test of significance on the difference in AUROC [Delong and Carolina,
1988].

3.7

Differential contribution of cis-regulatory elements to higher order
chromatin structure and expression of the CFTR locus

These results further demonstrate the importance of enhancers to CFTR expression: the authors investigate the long-range 3-D structure around CFTR and
demonstrate different topological interactions in different cell types. Removal of the
CTCF and cohesin proteins or their insulator CREs alters the enhancer/promoter
interactions; removal of known enhancer CREs significantly decreases CFTR expression. Interestingly, the authors demonstrate that the local topologically associating
domain (TAD) may be disrupted without ablating CFTR expression, which suggests
a potential compensatory mechanism of maintaining critical enhancer-promoter interactions; however, disruption of these enhancers decreases expression regardless of
overall chromatin structure. [Yang et al., 2015].
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3.8

Direct GR Binding Sites Potentiate Clusters of TF Binding across
the Human Genome

The authors demonstrate that clusters of the glucocorticoid receptor (GR), a
transcription factor, interact cooperatively over long ranges to produce regulatory response to glucocorticoid hormones. This cooperative effect indicates that TF binding
sites do not necessarily function independently; this implies that the most effective
enhancer-identifying models studied in this proposal may be those that can learn from
both individual motifs and larger-scale patterns of motifs [Vockley et al., 2016].

3.9

Discriminative prediction of mammalian enhancers from DNA sequence

This paper describes Kmer-SVM, which is the precursor to the LSGKM model,
which we implemented. The authors train a SVM to distinguish random genomic
locations from known enhancer sites. Kmer-SVM uses k-mer counts as feature vectors
and measures their similarity with the spectrum kernel. Interestingly, the authors
claim that the SVM is able to reflect the contribution of combinations of multiple
CREs to enhancer function [Lee et al., 2011].

3.10

Enhanced Regulatory Sequence Prediction Using Gapped k-mer
Features

This paper describes GKM-SVM, an improvement to the kmer-SVM model
that allows for gaps within the k-mer features. By allowing gaps in observed se-
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quences, a non-zero frequency may be estimated for longer sequences that are only
rarely observed in a given genomic segment. GKM-SVM is implemented and extended in the LS-GKM model. This allows the user to specify the motif size (word
length) and number of informative bases within the motif, which better models the
physical interaction between TFs and CREs. GKM-SVM significantly outperforms
kmer-SVM, particularly at long word-length [Ghandi et al., 2014].

3.11

Functional analysis of a promoter variant identified in the CFTR
gene in cis of a frameshift mutation

The authors describe the deleterious functional consequence of a CFTR promoter variation in concert with two disease-causing CFTR mutations. In this patient, both alleles of CFTR were affected by variants which cause near-total (but
not complete) loss of functional CFTR protein; however, the authors discovered a
third variant in the CFTR promoter, which they demonstrated to further decreases
CFTR expression. This underscores the importance of understanding the regulation
of CFTR and demonstrates that altered expression levels can potentially affect Cystic
Fibrosis disease state [Viart et al., 2012].

3.12

Genomic approaches for the discovery of CFTR regulatory elements

The authors review several studies forming the basis of the current understanding of the 3-D chromatin structure around CFTR. Numerous DNase hypersensitivity
sites mark accessible regions of chromatin in and around CFTR, many of which were
shown to physically interact with the CFTR promoter. Some sites have been con41

firmed as enhancers or insulators; certain individual sites are shown to be active
in a cell-type-specific manner, indicating a role in differential expression across cell
types [Ott and Harris, 2011].

3.13

Jointly characterizing epigenetic dynamics across multiple human
cell types

The authors describe the IDEAS genome segmentation model that is the first
step in our enhancer-analysis workflow. In contrast to previous models such as
ChromHMM that consider cell-type-specific data independently, IDEAS uses a layered set of HMMs to jointly learn from cell-type specific features and position-specific
features. The authors demonstrate the states generated by IDEAS are significantly
more reproducible than with other segmentation tools [Zhang et al., 2016].

3.14

Machine Learning Applications in Genetics and Genomics

This review provides a broad overview of several types of machine learning
methods used in genetics and some of the core concepts and trade-offs involved: comparing supervised and unsupervised methods; generative (modeling the full feature
set of each class) and discriminative (modeling the decision boundary) classifiers; and
discussing the trade-off between model accuracy and model interpretability. An interesting point regarding the difficulty of encoding prior knowledge into non-probabilistic
models (such as random forests and artificial neural networks) suggests that our focus on probabilistic models is a good choice to allow inclusion of our prior knowledge
regarding enhancer location and activity [Libbrecht and Noble, 2015].
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3.15

Mapping and analysis of chromatin state dynamics in nine human
cell types

This article describes the foundational research leading to the development,
validation, and application of the ChromHMM genome segmentation model. The
authors integrate 90 ChIP-seq datasets (at least nine chromatin marks across nine
cell types) by concatenating the cell-type data into a single track to train a HMM.
The paper demonstrates that linking the patterns of enhancer and promoter regions
with gene expression data and TF-binding motif enrichment and expression enables
the prediction of gene-regulatory networks [Ernst et al., 2011].

3.16

Molecular and functional analysis of the large 5’ promoter region of
CFTR gene revealed pathogenic mutations in CF and CFTR-related
disorders

The authors examine the effect of seventeen mutations in the CFTR promoter,
finding that promoter mutations may increase or decrease the expression of CFTR
and may behave differently across cell types. The authors postulate that promoter
mutations can alter its interaction with enhancers and other regulatory regions [Giordano et al., 2013].

3.17

The Relationship Between Precision-Recall and ROC Curves

This article summarizes and examines the connection between two popular
methods of classification model evaluation, the Precision-Recall Curve (PRC) and
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Receiver Operating Characteristic (ROC) curves. Each curve examines true positive
rate (i.e. sensitivity or recall) in contrast to another quality measurement and is
parameterized by varying cut-off score between “positive” and “negative” results.
The comparison for the PRC is precision, the percentage of positive predictions that
are true positives; the comparison for the ROC is false positive rate. The authors
note two important features of the PRC that lead us to examine both the PRC
and ROC in our analysis: first, that the PRC is a more sensitive gage of algorithm
performance when the positive and negative training sets are imbalanced; and second,
that optimizing the area under the ROC may not optimize the area under the PRC.
[Davis and Goadrich, 2006]

3.18

Variant Cystic Fibrosis Phenotypes in the Absence of CFTR Mutations

Non-classic Cystic Fibrosis is described as CF disease that affects only a subgroup of the typical organ systems (respiratory system, gastrointestinal system, sweat
glands, and vas deferens), which accounts for approximately 10% of Cystic Fibrosis
cases. The authors genotyped CFTR in 74 patients with non-classic CF in order
to investigate whether non-classic CF was associated with CFTR mutations. CFTR
mutations were not detected in 40% of patients and only a single CFTR mutation
could be detected in a further 20%; the subset of patients in the family studies were
demonstrated to have functional CFTR protein. This paper demonstrates that clinical
Cystic Fibrosis phenotypes can be observed without demonstrable CFTR mutation
or CFTR dysfunction. This may point to a genetic defect in other pathways that
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interact with CFTR; however, these results also demonstrate the need to investigate
regions that affect the expression of CFTR without altering its intrinsic function.
Unaffected organ systems also suggest a potential regulatory defect that may alter
expression in different ways in different tissues [Groman et al., 2002].
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CHAPTER 4

METHODS

4.1

Overview

To begin to identify and characterize novel CFTR enhancers and their observed
genetic variation, we gathered publicly-available and pre-publication epigenetic data
from ten immortalized cancer cell lines and constructed a machine-learning pipeline
to predict regions of interest. We used the IDEAS genome segmentation model to
identify broad regions of interest (scale: hundreds of base-pairs) and used the resulting
enhancer-associated sequences to train the LSGKM k-mer classifier to identify these
segments by sequence (scale: tens of base-pairs). Finally, we used the DeltaSVM
variant-scoring model to assess variants based on their predicted gain or loss of enhancer function. We often focus our analysis on the CFTR Topologically Associating
Domain (TAD), the local chromosomal neighborhood with which CFTR most often physically interacts, as reported by Dixon et al. in human embryonic stem cells
(hESC) at 40 kilobase resolution [Dixon et al., 2012].
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4.2

Choice of Cell Lines and Experiment Types

We added chromatin-accessibility, histone-modification, and TF-binding data
from four additional cell types (A549, Caco-2, Calu-3, and PANC-1) to the IDEAS
genome segmentation model (IDEAS36) published by Zhang et al. and trained a 34state genome segmentation model across ten total cell types. Though we are primarily
interested in the epithelial cell types relevant to CF disease (A549, Caco-2, Calu-3,
PANC-1), the IDEAS model is able to “share information across cell lines,” and
should produce a better segmentation in our cell types of interest with the inclusion
of more data [Zhang et al., 2016]. We assigned labels to the resulting 34 states based
on overlap between our model and IDEAS36 in the shared cell types and generated
genome browser tracks for visualization of the resulting states.
We chose both Calu-3, a lung epithelial cell with high CFTR expression, and
A549, a lung epithelial cell with moderate-to-low CFTR expression, with the hope
that the contrast between the datasets will help the model better learn CFTR regulatory features. During the analysis, we learned that PANC-1 shows lower CFTR
expression than we originally expected (see Table 4.3); however, similarly to A549, we
kept the cell line in the majority of our analysis and SVM-training pipeline in order
to learn from full range of CFTR expression in our data. In addition to (or sometimes
in place of) PANC-1, we cut-in A549 for the final CFTR enhancer and variant analysis. Table 4.2 and Table 4.3 summarize the types of immortalized cell lines used,
their corresponding tissue types, and their general expression level of CFTR. (Table 4.3 contains measurement in Reads per Kilobase of transcript per Million mapped
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reads (RPKM) and Fragments per Kilobase of transcript per Million mapped reads
(FPKM); these two measurements are not strictly comparable, but suitable for our
purposes of describing the rough order of magnitude of expression.)
Table 4.1: Experiment Types for IDEAS Training

Inquiry

Experiment

Target

Associated Effect

Chromatin Modification
Chromatin Modification
Chromatin Modification
Chromatin Modification
Chromatin Modification
Chromatin Modification
Chromatin Modification
Chromatin Modification
Transcription Factor
Transcription Factor
Open Chromatin
Open Chromatin
Open Chromatin
Control

ChIP-seq
ChIP-seq
ChIP-seq
ChIP-seq
ChIP-seq
ChIP-seq
ChIP-seq
ChIP-seq
ChIP-seq
ChIP-seq
DNase-seq (Duke)
DNase-seq (UW)
FAIRE-seq
ChIP-seq

H3K4me1
H3K4me2
H3K4me3
H3K9ac
H3K27ac
H3K27me3
H3K36me3
H4K20me1
POLR2A
CTCF
n/a
n/a
n/a
None

Gene Activation
Gene Activation
Gene Activation
Gene Activation
Gene Activation
Gene Repression
Active Gene Body
Gene Activation
mRNA Transcription
Insulator
Accessibility to TFs
Accessibility to TFs
Accessibility to TFs
n/a

Table 4.2: Cell Types of Immortalized Cell Lines
Cell Line Cell Type
A549
Caco-2
Calu-3
GM12878
H1-hESC
HeLa-S3
HepG2
HUVEC
K562
PANC-1

4.3

Lung (Alveolar Basal) Epithelial Adenocarcinoma
Colon Epithelial Adenocarcinoma
Lung Epithelial Adenocarcinoma
Lymphoblast
Embryonic Stem Cell
Cervical Cancer
Liver Carcinoma
Umbilical Vein Endothelial
Myelogenous Leukemia
Pancreas Duct Epithelial Carcinoma

Data Acquisition and Pre-Processing

To supplement the original IDEAS model [Zhang et al., 2016] with additional
cell-type-specific information, we acquired the original source datasets—ChIP-seq
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Table 4.3: CFTR Expression of Cell Lines for IDEAS Training
Cell Line Typical Expression Relative
IDEAS36 Expression
(TPM or FPKM) Expression Included Source
Calu-3
Caco-2
GM12878
A549
H1-hESC
HeLa-S3
K562
PANC-1
HepG2
HUVEC

74 FPKM
26 TPM
0.4 TPM
0.4 TPM
0.18 TPM
0.1 TPM
0.01 TPM
0.01 TPM
0 TPM
0 TPM

High
High
Moderate
Moderate
Low
Low
Slight
Slight
Negligible
Negligible

No
No
Yes
No
Yes
Yes
Yes
No
Yes
Yes

[Petryszak et al., 2016]
[The Human Protein Atlas, 2017, Uhlen
ENCODE Accession: ENCSR843RJV
[The Human Protein Atlas, 2017, Uhlen
ENCODE Accsssion: ENCSR537BCG
[The Human Protein Atlas, 2017, Uhlen
[The Human Protein Atlas, 2017, Uhlen
ENCODE Accssion: ENCSR000BYM
[The Human Protein Atlas, 2017, Uhlen
[The Human Protein Atlas, 2017, Uhlen

et al., 2015]
et al., 2015]
et al., 2015]
et al., 2015]
et al., 2015]
et al., 2015]

Table 4.4: Source Data Types
Data Type

GM12878 H1-hESC HeLa-S3 HepG2 HUVEC K562 A549 PANC-1 Caco-2 Calu-3

H3K4me1
BW
H3K4me2
BW
H3K4me3
BW
H3K9ac
BW
H3K27ac
BW
H3K27me3
BW
H3K36me3
BW
H4K20me1
BW
POLR2A
BW
CTCF
BW
DNase-seq (Duke) BW
DNase-seq (UW) BW
FAIRE-seq
BW
Control
BW

BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW

BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW

BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW

BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW

BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW
BW

BAM BAM
BAM
BAM BAM
BAM
BAM BAM
BAM
BAM
BAM
BAM
BAM
BAM
BAM BAM
BAM
BAM BAM

SRA
BAM SRA
SRA
BAM
BAM SRA

BAM
BED
BAM
BAM SRA

data describing chromatin modifications and transcription factor binding and multiple
measures of chromatin accessibility for six immortalized cell lines–and corresponding
raw data sets for four additional immortalized cell lines. The experimental data types
used to train IDEAS36 are listed in Table 4.1, with a high-level summary of the interpretation of the associated feature or chromatin mark [Barth and Imhof, 2010]. (We
note that these designations are quite broad and that the precise effect of any one histone modification is dependent on its localization in the genome and interaction with
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other histone and DNA features–hence the need for sophisticated pattern recognition.)
Ultimately, we trained the IDEAS model on 115 datasets, of which 84 represent the
original source datasets for IDEAS and 31 represent our additional source data. All
datasets are originally derived from the collection of individual DNA fragment reads
from a next-generation DNA sequencing experiment and are ultimately represented
as a signal intensity measured at any given genomic coordinate (a one-dimensional,
discrete spatial coordinate), i.e. a signal track. However, because the data are the
result of multiple studies across many labs, they were acquired in several different
formats representing various stages in the process of converting raw sequence reads
to signal tracks. As a result, generating datasets comparable to the original IDEAS
source data was a complex task requiring the use of a number of commonly-available
bioinformatics software tools. The ultimate required input format for the IDEAS
model is a text file containing the maximum or mean signal per non-overlapping
200 bp segment of the genome. Broadly, raw sequence reads (FASTQ format) are
aligned to the reference genome, converting them to Binary Alignment Map (BAM)
format; the read depth at each position is calculated, normalized, and smoothed to
produce a signal track (bigWig format); finally, the signal files are windowed to produce the IDEAS-ready input. This overview is shown in Figure 4.1 and the source
data types for each experiment are detailed in Table 4.4.

4.3.1

Computation
We used both the Alabama Supercomputer and the HudsonAlpha Institute

for Biotechnology compute clusters for data acquisition and pre-processing. The se-
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Figure 4.1: Data pre-processing overview.

quence alignments and use of the IDEAS prepMat software described in Section 4.3.3
were performed at HudsonAlpha; other pre-processing tasks were performed on the
Alabama Supercomputer.

4.3.2

Sequencing Data Acquisition
We downloaded the original 84 datasets used in IDEAS, which were available

in bigWig (signal track) format and had been generated and uniformly processed as
part of the ENCODE project [Hoffman et al., 2013]. We searched the ENCODE
database for matching experiments in A549, PANC-1, and Caco-2 immortalized cell
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lines and downloaded the aligned reads in BAM format. Only 25 out of a potential 42
experiments were available, representing a complete set for A549 and partial sets for
PANC-1 and Caco-2. Across the 25 available experiments, we obtained 106 BAMs,
including biological replicates (experiments performed on separate samples from the
cell line) and technical replicates (multiple sequencing runs of the same sample). We
obtained published and pre-publication sequencing data for 6 available experiment
types (out of 14 possible) in Calu-3 cells from the National Center for Biotechnology
Information Gene Expression Omnibus (NCBI GEO) database and direct File Transfer Protocol (FTP) transfer from our collaborators [Fossum et al., 2014]. Calu-3 data
were in Sequence Read Archive (SRA) format, except for the DNase-seq experiment,
which we ultimately downloaded in Browser Extensible Data (BED) format (genomic
coordinates of peaks) due to difficulties we encountered aligning the DNase-seq data.
Raw source data files are listed in Appendix A; where filenames are not descriptive of experiment type and target, we include a brief description. Table A.1 and Table A.2 list filenames and ENCODE accession identifiers for the BAM-format files that
we downloaded from the ENCODE database (https://www.encodeproject.org/). Table A.3 and Table A.4 list the pre-processed BigWig signal tracks we downloaded from
the Wiggler project. (The Wiggler datasets are available from https://sites.google.com/
site/anshulkundaje/projects/wiggler.)

Table A.5 shows the datasets downloaded

from the NCBI GEO. Table A.6 describes the datasets obtained directly from our
collaborators in the Ann Harris Lab at Northwestern University.
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Figure 4.2: Data pre-processing detail.

4.3.3

Sequence Data Processing
Since we obtained data at multiple stages of processing, we attempted to

replicate the ENCODE processing pipeline to the maximum extent possible, using
industry-standard tools to convert raw or aligned sequence data to bigWig signal
tracks. Figure 4.2 shows the workflow for all software tools; each file-type and major
process includes the count input and output files to clarify where the 196 raw source
files were combined into the 115 IDEAS-ready inputs.

53

We unpacked the Calu-3 SRA files into FASTQ using the SRA Toolkit from
the National Center for Biotechnology Information (NCBI) [Leinonen et al., 2011];
next, we aligned the reads to the reference genome (build hg19) using BWA and
standard settings for single-end short-read sequences [Li and Durbin, 2010]. For
A549, PANC-1, and Caco-2 BAMs, we merged technical replicates using the Samtools
merge software [Li et al., 2009]. At this point, we had BAM files for 99 sequencing
experiments.
Next, we combined biological replicates and normalized the read counts to
generate uniform signal tracks comparable to the ENCODE-published data. We used
Phantompeakqualtools [Kharchenko et al., 2008, Landt et al., 2012] to estimate the
fragment length of the input DNA, which is a necessary parameter for pre-IDEAS
normalization. BAMs were normalized, combined by experiment type, and converted
to bedGraph signal track format using the ENCODE consortium’s Align2rawsignal
tool [Hoffman et al., 2013, ENCODE Project Consortium et al., 2012]. Twentynine files represented the total summary of all available data for each respective cell
type and experiment type combination; the remaining two were both A549 Control
sets that could not be combined at this step due to differing read-lengths. The
bedGraph files were converted to bigWig format using the UCSC Genome Browser
bedGraphToBigWig tool [Kent et al., 2002].
We had also downloaded and processed raw sequences in SRA format for
DNase-seq in Calu-3, but were unable to correctly align the reads to the reference
genome; instead, we downloaded the signal peaks in bedGraph format and converted
them to bigWig format using the UCSC Genome Browser bedSort and bedGraphTo54

BigWig tools. This dataset was a departure from our otherwise-uniform processing
pipeline; however, excluding this biologically important dataset would have had a
significantly more deleterious effect on the final model than any minor differences in
normalization versus the other DNase-seq datasets.
At this stage, we had 116 normalized signal tracks. The final preparation step
required a custom tool, prepMat, which is included with the IDEAS software package. The prepMat software generates one text file per combination of cell type and
experiment type containing a summarized signal intensity per 200-bp window. Like
the originally published IDEAS36 model, we chose the default summary function—
the maximum signal per window—and did not apply any additional standardization
with prepMat. Using prepMat, we excluded the ENCODE DAC Blacklisted Regions
and Duke Blacklisted Regions from the training data; these regions are difficult to
sequence with whole genome sequencing technology, and their removal is standard
practice [ENCODE Project Consortium et al., 2012]. The final pre-processing result
was 115 IDEAS-ready datasets, 31 of which were not included in the original IDEAS
segmentation.

4.4

IDEAS Genome Segmentation

Using the 115 processed datasets, we used the IDEAS model to produce ten
cell-type specific genome segmentation tracks. We trained the model on all datasets
simultaneously using default settings and manually assigned labels to the resulting
states by inspection of overlap with the published IDEAS segmentation [Zhang et al.,
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2016], which was downloaded via the Pennsylvania State University (PSU) Genome
Browser’s Table Browser [Karolchik et al., 2004].

4.4.1

Computation
We trained the IDEAS model on the HudsonAlpha Institute for Biotechnology

compute cluster, allocating twelve processors and maximum RAM. We did not perform a rigorous analysis of performance, though we noted runtime of approximately
14 hours and maximum RAM usage of approximately 40 GB.

4.4.2

IDEAS Label Assignment
Our resulting segmentation contained 34 predicted states, which then required

manual assignment of semantics. It is important to note that, as the primary focus
of our study examines enhancer-related states and, to a lesser extent, promoterassociated states, other state assignments were given a more-cursory examination.
As the originally-published IDEAS segmentation (IDEAS36) contained 36 distinct
states, we attempted to map our states onto the labels for the original model by
examining overlap between our segmentation and IDEAS36. We explored three different approaches to mapping: a state-focused view using either all six cell types or
a single cell type, and a label-focused view.

4.4.2.1

State-Focused Mapping With Six Cell Types

In the state-focused mapping approach, we sought to assign the top-ranking
available IDEAS36 label to each of our 34 unlabeled states. For each of the six
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Table 4.5: Example Label Overlap (State 3, All Cell Lines)
Count

Percent

Label

1,805,990
4,744
1,388,242
173,550
87,130
83,327
16,650
14,604
13,580
7,733
4,662
3,907
2,258
1,605
843
739
564
450
436
309
202
199
66
53
51
50
18
9
6
2
1

100 %
0.26 %
76.87%
9.61 %
4.82%
4.61%
0.92%
0.81%
0.75%
0.43%
0.26%
0.22%
0.13%
0.09%
0.05%
0.04%
0.03%
0.02%
0.02%
0.02%
0.01%
0.01%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Total
No Overlap
Low1
Quies
LowReprW
FaireW2
FaireW1
EnhWF3
Zero
Pol2
EnhWF1
Ctcf
Repr2
ElonW
Repr1
Art2
DnaseD2
PromF2
Low2
Art1
Elon
DnaseD1
CtcfO
ReprD
PromF1
EnhWF2
Gen5
Gen3
Gen3Ctcf
PromP
EnhF

cell type segmentations in common between our unlabeled segmentation and the
originally-published IDEAS segmentations, we used standard UNIX command-line
tools to separate our 34 unlabeled states into BED files containing the coordinates of
each 200 bp window assigned to the state. For each, we used the bedtools intersect
program [Quinlan and Hall, 2010] to join overlapping regions in the corresponding
cell type’s IDEAS36 segmentation BED file. We concatenated the six cell types into
a single text file recording overlaps, resulting in one overlap file for each of the 34
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unlabeled states. We verified that all overlaps were 199-200 bp long, which allowed
the counts overlapping segments to be used as a surrogate for the total length of
overlap. Using standard UNIX command-line tools, we isolated, sorted, and counted
the number of overlapping labels for each state; in Microsoft Excel, we recorded
each state’s number of segments overlapping no IDEAS36 labels and, per-label, the
overlap count, and overlap percentage. Table 4.5 shows an example of a ranked list of
overlapping labels for State 3; italicized text represents the label ultimately assigned
to the state in this mapping exercise.
Beginning with state zero, we examined the list of overlapping labels and
noted the top-ranked label as that state’s candidate label. We then searched all other
unlabeled states to see if that label was better-assigned elsewhere. If another state had
that label at a higher percentage-of-total-overlap, we gave the other state preference—
except in cases where the state having the label at a higher ranking represented a
significantly smaller absolute number of overlaps. (If State A had the best-ranked
label overlapping 50% of 1,000,000 segments, we would avoid re-assigning the label to
State B overlapping 70% of 1,000 segments.) If the candidate label was re-assigned
to a different state, we repeated the process with the second-highest ranking label
from the starting state, and so forth; otherwise, if the starting state was the best
assignment for the candidate label, it was retained as the final label selection. We
repeated this process with the next unlabeled state.
We hoped the mapping process would be straightforward, given that we were
mapping 34 states onto 36 from IDEAS36; however, it proved to be a difficult task
due to the common replication of a given, top-ranking label across multiple states.
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Unfortunately, this lead to the assignment of some surprisingly-low-ranked states
(often less than fifth-ranked) representing only a small amount of overlap (1% or
less). We recognize that this introduces a significant amount of uncertainty and
subjectivity into the mapping process; however, we also recognize that the changing state assignments, demonstrated by the non-unique top-ranked labels, indicates
that the additional training data is having a measurable impact on the resulting
segmentations–one which we hope indicates a higher-quality result than we would
have obtained by training separately on each dataset of interest.
After the initial pass at mapping to IDEAS36, we observed that the strong
enhancer state from IDEAS36 (Enh) had not been assigned to any states, as it was
not the top-ranked label for any state, though it was a strong third for State 7 at
20% overlap. As this state is the primary target of our study, we changed our label
for state 7 to Enh. We then worked backward in the process, checking for any states
which would have been assigned the now-available top-ranked label, made changes as
necessary, and continued working backwards until all changes were propagated.

4.4.2.2

State-Focused Mapping With One Cell Type

Since the mapping considering all six cell types’ overlaps en mass resulted in
some uncertainty regarding the assignment of closely-related labels, we attempted another mapping using only our model’s overlap with IDEAS36 in the GM12878 tracks.
As described in Section 4.4.2.1, we again sought to assign the best available IDEAS36
label to each of the 34 unlabeled states. We repeated the segment-overlapping and
label-ranking processes using only the GM12878 segmentations from IDEAS36 and
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our model. We expected that the use of a single cell type might help deconvolute
multiple states that overlap with the same IDEAS36 label; however, in practice, we
found the single-cell-type mapping to be more difficult due to the lower total counts
of segments for uncommon states.

4.4.2.3

State-Focused Mapping to ChromHMM in GM12878

The IDEAS36 model was originally assigned semantic labels, in part, by examining the overlap with the ChromHMM genome segmentation model [Ernst and Kellis, 2012]. We attempted a third state-focused mapping by examining the overlap in
GM12878 between ChromHMM our IDEAS model. We downloaded the ChromHMM
segmentation from the UCSC Genome Browser’s Table Browser [Karolchik et al.,
2004] and applied the methodology described in Section 4.4.2.1. As the ChromHMM
model contains 25 states, we expected a more straightforward mapping, since the
IDEAS36 model contains several duplicate states which we suspected were clouding the earlier mappings; however, we again found the process more difficult with a
smaller set of label choices for each state, as a greater number of subjective judgment
calls were necessary.

4.4.2.4

Label-Focused Overlap (All Cell Lines)

We explored a fourth mapping method, which was inspired by the necessity of
selecting the best-matching state for the strong enhancer label (as opposed to selecting
the best-matching label for a given state). For this method, we again employed
standard UNIX command-line tools to count and sort the segmentation intersections
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described in Section 4.4.2.1, except we counted and ranked states within each label.
States were assigned to labels in a similar fashion, seeking the best-fit state for each
label. By nature, this method resulted in 34 out of 36 IDEAS36 being used; however,
we still found closely-related states and closely-related labels difficult to assign with
objectivity.

4.4.2.5

Final Mapping

Eric Mendenhall determined the final mapping, making alterations to the allcell-types, state-focus mapping described in Section 4.4.2.1 by comparison to other
mapping results, examination of the underlying ChIP-seq data, and assessment of
the segmentation at genomic regions of interest. The final mapping is described in
Table 4.6; each state is given a short label, a description, and a color for visualization.
For consistency, we chose colors to correspond closely to the IDEAS36 color scheme.

4.4.3

Segmentation Visualization
We wrote Python scripts to process the IDEAS output for visualization and

further analysis. For most applications, including the next stage of model training,
we merged contiguous segments within states. For example, in the case of training
a classifier to recognize DNA segments from a given label, artificially segmenting the
regions into 200 bp segments risks destroying potentially relevant motifs within the
training data. First, contiguous BED regions were merged if they share the same
label. Then, based on a key file containing the final mapping shown in Table 4.6, we
annotated the state-merged BED file with labels, colors, and other Genome Browser
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Table 4.6: Final State Assignments
State
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33

Label

Description

Track Color

Track Color (RGB)

Elon
Low1
Pol2F
Low2
Ctcf
Low3
EnhWF
Enh
LowF
PromFC
Faire2
LowRep
Faire1
PromFA
Blank
Zero3
FaireLow
CtcfO
Zero2
Repr
Enh2
Gen5
EnhWF2
FaireW2
PromFF
Zero1
PromP
Pol2
Tss
Gen3
Art
EnhW
Elon2
ArtP

Elongation
Low Signal
POL2 Binding Site (FAIRE)
Low Signal
CTCF Binding Site
Low Signal
Weak Enhancer (FAIRE)
Strong Enhancer
Low (FAIRE)
Candidate Promoter (FAIRE)
Open Chromatin (FAIRE Signal)
Low Signal / Repressed
Open Chromatin (FAIRE Signal)
Active Promoter (FAIRE)
Blank/Masked in IDEAS36
Low Signal
Low Signal / Open Chromatin (FAIRE)
Occupied CTCF Binding Site
Low Signal
Repressed
Strong Enhancer
Gene 5’ End
Weak Enhancer (FAIRE)
Weak Open Chromatin (FAIRE)
Promoter (FAIRE)
Low Signal
Poised Promotor
RNA Polymerase Binding Site
Transcription Start Site
Gene 3’ End
Artificially High Signal Region
Weak Enhancer
Elongation
Artificially High Signal Region

Dark Green
Light Gray
Light Red
Light Gray
Blue
Light Gray
Yellow
Orange
Light Gray
Light Red
Yellow-Green
Medium Gray
Yellow-Green
Light Red
Black
V Light Gray
Yellow-Green
Blue
V Light Gray
Dark Gray
Orange
Light Green
Yellow
Yellow-Green
Light Red
V Light Gray
Purple
Red
Red
Light Green
Navy
Yellow-Orange
Dark Green
Navy

0,102,0
192,192,192
255,153,153
192,192,192
0,0,204
192,192,192
255,255,0
255,128,0
192,192,192
255,153,153
236,255,154
160,160,160
236,255,154
255,153,153
0,0,0
244,244,244
236,255,154
0,0,255
244,244,244
96,96,96
255,128,0
0,204,0
255,255,0
236,255,154
255,153,153
244,244,244
204,153,255
255,0,0
255,0,0
0,204,0
0,102,102
255,232,154
0,102,0
0,153,153

track information. The resulting tracks may be visualized using programs such as the
UCSC Genome Browser or the Integrative Genomics Viewer (IGV) [Thorvaldsdóttir
et al., 2013, Robinson et al., 2011].

4.4.4

Comparative Analysis of Segmentations
To compare the performance of the published IDEAS model (IDEAS36) and

our IDEAS model (10-Cell IDEAS), combined each set of IDEAS states into broad cat62

egories (see Table 4.8 and Table 4.7) and used these categories to calculate the changes
in predicted percent composition of genome by state, count of segments by state, and
length of segments by state. To calculate the percent composition of the genome by
state, we used the total size of the hg19 reference sequence (3,137,161,264 bp). As
the 10-Cell IDEAS and IDEAS36 segmentation tracks did not cover all bases in hg19,
we calculated the difference between total assigned bases and the hg19 reference size
and categorized the difference as “Blank/Excluded” bases. In the 10-Cell IDEAS segmentation, this category also included regions assigned the Blank label. Percentages,
counts, and lengths reported are all calculated as the change from IDEAS36 to 10-Cell
IDEAS, i.e. 10 Cell IDEAS − IDEAS36. We repeated these calculations within
the CFTR TAD, normalizing the percentages-by-label to a total length of 800,000 bp.

Table 4.7: Category Assignment of IDEAS36 States
Enhancer Promotor Repressed

Gene Body Open Chromatin CTCF Low

Enh
EnhF
EnhW
EnhWF1
EnhWF2
EnhWF3

Elon
ElonW
Gen3
Gen3Ctcf
Gen5
Pol2

4.5

Tss
TssCtcf
TssF
TssW
PromCtcf
PromF1
PromF2
PromP

LowReprW
Repr1
Repr2
ReprD

DnaseD1
DnaseD2
FaireW1
FaireW2

Blank / Excluded

Ctcf
Art1 Difference vs. hg19
CtcfO Art2
Low1
Low2
Quies
Zero

Generation of Training and Test Sets

To prepare for training a SVM model, we used the IDEAS results to generate positive (training), negative (training), and test sets for whole-genome candidate
strong enhancers in K562, Caco-2, Calu-3, A549, and PANC-1 cell lines. For each
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Table 4.8: Category Assignment of 10-Cell IDEAS States
Enhancer Promotor Repressed Gene Body Open Chromatin CTCF Low
Enh
Enh2
EnhW
EnhWF
EnhWF2

PromFA
PromFC
PromFF
PromP
Tss

LowRep
Repr

Elon
Elon2
Gen3
Gen5
Pol2
Pol2F

Faire1
Faire2
FaireLow
FaireW2

Blank / Excluded

Ctcf
Art Blank
CtcfO ArtP Difference vs. hg19
Low1
Low2
Low3
LowF
Zero1
Zero2
Zero3

whole-genome set, we reserved 10% of the segments for the test set; segments were
randomly selected without replacement using R. We also generated positive and negative training sets for some cell lines of interest (Caco-2, Calu-3, PANC-1) using only
the candidate strong enhancers around the CFTR locus, as well as a more permissive
set of enhancer-related states. For the CFTR-localized sets, we did not reserve a
separate test set due to the small number of sequences.

4.5.1

Selection of Whole-Genome and CFTR Topologically-Associated
Domain Sets
For each of the three cell lines (Caco-2, Calu-3, and PANC-1), we generated

one primary and two secondary datasets for analysis: whole genome (WG) potential
strong enhancers, CFTR Topologically Associating Domain (TAD) potential strong
enhancers, and CFTR TAD putative enhancers—a more permissive set of enhancerlike areas that includes weak enhancers and flanking regions. The CFTR TAD sets
represent the local genomic region, approximately one megabase in size, with which
CFTR most often interacts physically; this is where CFTR-interacting enhancers
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are most likely to be found. For the CFTR TAD sets, we used bedtools intersect
to select chromosome 7, positions 116,840,000 through 117,640,000 from the IDEAS
output for each cell type. For the strong enhancer sets, we selected regions labeled
Enh1 or Enh2. For the putative enhancer set, we selected regions labeled Enh1,
Enh2, EnhW, EnhWF, or EnhWF2. Enhancer-region counts and summary statistics
of length are described in Table 4.9 for whole genome strong enhancers, Table 4.10
for the strong enhancer regions within the CFTR TAD, and Table 4.11 for the full
set of putative enhancers within the CFTR TAD.

Table 4.9: Whole Genome Strong Enhancer Sets (Unfiltered; States: Enh1, Enh2)

Cell
Caco-2
Calu-3
PANC-1
A549

Segment Count

Minimum

91,614
228,771
111,660
95,029

2
53
47
70

Segment Length
1st Quartile Median Mean
200
200
200
200

400
200
400
400

414
471
587
790

3rd Quartile
600
600
600
1000

Max
5,600
20,200
16,800
24,200

Table 4.10: Strong CFTR TAD Enhancer Sets (Unfiltered; States: Enh1, Enh2)

Cell
Caco-2
Calu-3
PANC-1

4.5.2

Segment Count

Minimum

1st Quartile

32
133
21

200
200
200

200
200
200

Segment Length
Median Mean
400
400
200

3rd Quartile

Max

600
600
400

1400
4400
1200

538
480
438

DNase Hypersensitivity and Segment Length Filtering
We note that the majority of predicted enhancer regions are from 200-600 bp

long, but the length distributions are significantly right-skewed with a small number
of very long segments. We know that the motifs making up a given enhancer are
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Table 4.11: Putative CFTR TAD Enhancer Sets (Unfiltered; States: Enh1, Enh2,
EnhW, EnhWF, EnhWF2)

Cell

Segment Count

Minimum

1st Quartile

152
141
90

200
200
200

200
200
200

Caco-2
Calu-3
PANC-1

Segment Length
Median Mean
200
400
300

3rd Quartile

Max

400
400
600

1600
4400
1600

349
463
449

Table 4.12: DNase Dataset Characteristics
Cell
A549
Caco-2
Calu-3
PANC-1

Number of Peaks

Combined Length (bp)

ENCODE/GEO Accession

225,895
61,676
91,063
64,513

33,898,870
9,251,400
13,750,513
9,676,950

ENCFF001VYQ
ENCFF638UFD
GSM1548076
ENCFF635TDK

unlikely to be thousands of base pairs long, being classically characterized as approximately 50 bp to 1,500 bp long [Blackwood and Kadonaga, 1998]; segments greater
than 2,048 bp also require recompilation of the LSGKM SVM model software. Furthermore, whole-genome sets each have on the order of 100,000 segments; preliminary
tests to train a support vector machine on these sets revealed an unacceptably-long
training time, which would make optimization of the subsequent model infeasible.
As DNA must be located in open chromatin regions for transcription factors
to bind, active enhancers must occur within these accessible reasons. Therefore, to
further increase the signal in our training sets, we filtered the strong enhancer regions
by intersecting with DNase hypersensitivity peaks. As a result of filtering, the wholegenome strong enhancer sets were reduced to more tractable sizes of 20,000-60,000
segments, which had a more biologically-reasonable maximum size of approximately
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150 bp. Counts and length statistics of the resulting regions are described in Table 4.13.
For Caco-2, PANC-1, and A549, we downloaded DNase (UW) experiment results from the ENCODE database in narrow-peak BED file format; the BED files
were processed using standard ENCODE methods using the hg19 build of the reference genome. When a choice of biological replicates was available, we selected the
replicate with the greatest number of peaks. For Calu-3, we used the same DNase
(Duke) BED file described in Section 4.3.2. Table 4.12 describes the characteristics
of each dataset. Again, intersections were calculated using bedtools intersect. We
discarded any resulting segments smaller than 12 bp, which would not have been
trainable under our planned search space of the SVM models.
For the CFTR TAD strong and putative enhancer sets, we determined that
DNase-filtering was inappropriate, as it resulted in extremely few remaining segments.
Instead, we removed any segments less than 12 bp or greater than 1000 bp in length.
Final counts and lengths are summarized in Table 4.14 and Table 4.15, respectively.

Table 4.13: Whole Genome Strong Enhancer Sets (DNase-filtered; States: Enh1,
Enh2)

Cell
Caco-2
Calu-3
PANC-1
A549

Segment Count

Minimum

1st Quartile

19,619
28,227
19,214
59,240

25
12
25
20

150
125
150
150
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Segment Length
Median Mean
150
151
150
150

137
129
139
142

3rd Quartile

Max

150
151
150
150

150
151
150
290

Table 4.14: Strong CFTR TAD Enhancer Sets (Length-Filtered; States: Enh1,
Enh2)

Cell

Segment Count

Minimum

1st Quartile

27
124
20

200
200
200

200
200
200

Caco-2
Calu-3
PANC-1

Segment Length
Median Mean
400
400
200

385
374
400

3rd Quartile
500
400
400

Max
1,000
1,000
1,000

Table 4.15: Putative CFTR TAD Enhancer Sets (Length-Filtered; States: Enh1,
Enh2, EnhW, EnhWF, EnhWF2)

Cell

Segment Count

Minimum

1st Quartile

146
132
83

200
200
200

200
200
200

Caco-2
Calu-3
PANC-1

4.5.3

Segment Length
Median Mean
200
200
200

307
364
371

3rd Quartile
400
400
400

Max
1,000
1,000
1,000

Enhancer Set Evaluation
To compare putative enhancers across cell types, we used bedtools to generate

two-way and three-way intersections between the Caco-2, Calu-3, and PANC-1 potential enhancer regions; for this analysis, we used the un-merged, 200 bp segments from
IDEAS so that the overlap totals would sum properly within each set. We used R
with commonly-available libraries (such as dplyr, tidyr, ggplot2, and VennDiagram)
to generate Venn diagrams as well as the aforementioned length statistics [Chen,
2016,Wickham and Francois, 2016,Sing et al., 2005,Wickham, 2017,Wickham, 2009,R
Core Team, 2016].
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4.5.4

Generation of Positive-Training, Negative-Training, and Test Sets
Using R, we isolated 10% of the genomic regions in each of the filtered, whole-

genome data sets to use as a test set for evaluation of the final SVM model. We did
not segregate a separate validation set, as the LSGKM software can automatically
perform n-fold cross validation from a single training set input. Therefore, we refer
to the remaining 90% of filtered regions as the whole-genome training sets. For the
smaller CFTR TAD sets we did not isolate a test set, as there were so few training
examples to begin with.
We uploaded the BED files for the Filtered WG Strong Enhancers (Training
Sets), Filtered WG Strong Enhancers (Test Sets), CFTR TAD Strong Enhancers, and
CFTR TAD Putative Enhancers to the Beer Lab kmer-SVM web server [Fletez-Brant
et al., 2013]. (Kmer-SVM is the precursor to the LSGKM SVM model we employ.) For
each training and test dataset, we used the “Generate Null Sequence” tool with default
parameters to generate a set of randomly-selected genomic DNA, which is matched
for GC-content and repetitive-sequence-content, for use as the negative training sets.
Each negative set is approximately 10 times larger than the corresponding positive
set. Next, we used the “Extract Genomic DNA” tool to fetch the hg19 genomic
sequences corresponding to the supplied BED coordinates and the “Filter Sequences
by Length” tool to perform the previously-described length filtering. This resulted
in the FASTA-format sequence data required for input into the subsequent LSGKM
analysis.
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4.5.5

Preliminary Dataset (K562)
Prior to the data collection and IDEAS training, we generated a preliminary

dataset for exploratory analysis using the previously-described methods; however,
the preliminary dataset was generated from the published IDEAS36 model for the
K562 cell line, as opposed to the K562 output from our 10-cell-type-model. We selected K562 for preliminary analysis due to its status as a well-characterized cell
line, the abundance of available ENCODE data (as an ENCODE tier-one cell line),
and applicability to other ongoing projects in the Mendenhall lab. We isolated the
Enh-labeled states from K562 (IDEAS36, whole-genome), filtered by DNase hypersensitivity peaks, merged the contiguous segments, and used the kmer-SVM web server
to generate the positive and negative sequence sets. As this set was generated for
preliminary analysis of the IDEAS output, we did not isolate a test set.

4.6

LSGKM Model Training and Optimization

Using our preliminary dataset of potential K562 enhancers, we trained multiple
cross-validation iterations of the LSGKM support vector machine model to discover
optimal parameters for enhancer motif discovery. We performed an extensive search
of the LSGKM parameters related to sequence length and content; then to examine
behaviors of the model’s available kernel functions, we used the initial results to
narrow the search space for optimizing the model on the whole-genome Caco-2, Calu3, PANC-1, and A549 datasets. The total parameter search space is summarized in
Table 4.16.
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Table 4.16: Total LSGKM Parameter Search Space
Parameter Description

Lower Upper Parameter Parameter
Bound Bound Increment Count

L
K
D
C
Kernel
γ

4
3
0
0.001
N/A
0.0625

4.6.1

Motif length (bases)
Number informative positions within motif
Maximum number of mismatched bases
Cost of misclassification during training (margin hardness)
GKM, GKM + RBF, WGKM, WGKM + RBF
Spread of radial basis function transformation (inverse)

12
12
3
1000
N/A
16

+1
+1
+1
∗10
4
∗2

9
8
4
7
5

Computation
We used both the Alabama Supercomputer and the HudsonAlpha Institute for

Biotechnology compute clusters, varying frequently the number of processors (1 - 16)
and amount of RAM (4 GB - 120 GB) to balance minimizing individual model runtime
with efficient use of available resources on shared systems. We did not systematically
collect data for a rigorous analysis of runtime versus resource utilization; however,
we noted significant variation in runtime depending on model parameters, with runtimes under identical resources varying from approximately 8 hours - 144 hours, for
example. All cross-validation random number seeds were left as the default value (1)
except as described in Section 4.6.6. In general, we found the use of 4 processors and
approximately 10 GB of RAM to be sufficient for each cross-validation run, which
allowed us to run up to twelve cross-validations in parallel on the large-job queue on
the Alabama Supercomputer.
We used the LSGKM implementation of the Gapped k-mer SVM (gkm-SVM)
sequence classifier, LSGKM allows for larger-scale datasets and offers additional
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choices of kernel functions for sequence comparison, compared to the original gkmSVM implementation (R and Galaxy).

4.6.2

K562 Sequence-Length Parameter Search
In our preliminary analysis of K562, we focused first on the whole-number pa-

rameters for total sequence length (word length, L), number of informative positions
(K), and number of allowed mis-matches (D); these parameters model the underlying
biology of TF-binding motifs. In the model, word length L may vary from 3 to 12
(inclusive); K may vary from 1 to L (inclusive); D may vary from 0 to min{4, L−K}.
We excluded values of K less than 3 and L less than 4 from our initial search, judging
these extremely short sequences to be unlikely to accurately model TF-binding, as
transcription factors general bind to 8 bp to 20 bp of DNA at a time [Zambelli et al.,
2013]. We excluded D = 4 to minimize computation time, as Ghandi et al. reported
data indicating a potential ten-fold increase in computation time with the additional
allowed mismatch [Ghandi et al., 2014].
We trained and performed five-fold cross-validation on 163 models, stepping
through all possible combinations of 4 ≤ L ≤ 12, 0 ≤ K ≤ L, and 0 ≤ D ≤
(L − K) ≤ 3. At this stage, all models were trained using the fundamental gapped kmer kernel: estimated l-mer with truncated filter (GKM). To analyze the performance
of the models, adapted the R scripts distributed with the k-merSVM Galaxy software,
which use the ROCR R module to generate Receiver Operating Characteristic and
Precision-Recall curves and calculate the average Area Under the Receiver Operating
Characteristic curve (AUROC) and average Area Under the Precision-Recall Curve
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(AUPRC). We explored ranking models by AUROC and AUPRC, noting that they
gave generally-similar results for the top-ranking 10% of models, though differing
ordering within the set, and that AUPRC appears more sensitive. Ultimately, we
chose to primarily rank models on the sum of AUROC and AUPRC to give equal
weight to both measures, though we note that, unlike AUROC, the value of the sum
is not intrinsically meaningful.

4.6.3

K562 Kernel Search
To evaluate the effect of additional kernel transformations on the model per-

formance, we selected a subset of 12 of the K562 models: two each of top-ranked,
medium-ranked, and bottom-ranked combinations of L and K. All models selected
at this stage had maximum mismatch parameter D = 3, which was notably superior
across most most combinations of L and K. We trained 36 more models: twelve
each using the weighted GKM (WGKM) kernel, GKM with radial basis function
(GKM RBF) kernel, and weighted GKM with radial basis function kernel (WGKM
RBF). All four additional kernels build on the fundamental GKM kernel, adding additional transformations (and additional parameters). All models were selected from
non-consecutive positions within the AUC Sum ranking, in order to provide a wider
range of starting AUC metrics. We ranked the resulting models as described in Section 4.6.2. Table 4.17 describes the subset parameters and corresponding AUROC
and AUPRC under the standard GKM kernel described in Section 4.6.2.
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Table 4.17: Selected K562 Models for Kernel Search

4.6.4

L

K

Model Rating

ROC AUC (GKM)

PR AUC (GKM)

AUC Sum (GKM)

10
11
12
10
9
7

6
6
4
4
3
3

Good
Good
Medium
Medium
Poor
Poor

0.878
0.876
0.795
0.773
0.671
0.602

0.561
0.558
0.366
0.317
0.170
0.129

1.439
1.434
1.161
1.089
0.841
0.731

K562 Misclassification Cost Parameter Search
Next, we evaluated the effect of the misclassification cost parameter, C, on

model performance.

Using the same subset of top-ranked, medium-ranked, and

bottom-ranked models described in Section 4.6.3 (12 total), we varied C by powers of ten, as a logarithmic search is common strategy for tuning this standard SVM
parameter [Chang and Lin, 2011], and as using a base ten allowed us to interrogate
Lee’s recommended value of C = 10 for LSGKM. We trained an additional 6 variations on each model (72 models), varying C from 1000 to 0.001, having already
computed C = 1.0 while performing the kernel search. We ranked the total set of 84
models based on the sum of AUROC and AUPRC as described in Section 4.6.2.

4.6.5

Caco-2, Calu-3, and PANC-1 Sequence-Length Parameter Search
Based on the results of the experiments described in Section 4.6.2 and Sec-

tion 4.6.3, we selected D = 3 and the GKM RBF kernel as default parameters and
narrowed the search space of remaining sequence length parameters to 8 ≤ L ≤ 12
and 5 ≤ K ≤ (L − 3) ≤ 7. (With D fixed at D = 3, K is now constrained as
K + D ≤ L). For the standard SVM parameters, we set γ = 2.0 (the RBF radius),
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based on the recommendation included with LSGKM, and C = 1.0. This resulted in
12 combinations of parameters for further search.
We trained and cross-validated each the filtered, whole-genome candidate
strong enhancer training sets for Caco-2, Calu-3, and PANC-1 using the reduced
parameter search space to discover the optimal sequence length parameters in each
cell type (36 models).

4.6.6

Evaluation of Run-to-Run Variance
Before further tuning of the parameters for the Caco-2, Calu-3, and PANC-1

classifiers, we sought to quantify the variance in mean AUROC and AUPRC between
independent five-fold cross-validation runs in order to better determine the point of
diminishing returns from model tuning. We selected a top-performing model from Section 4.6.5 (Caco-2; L = 10, K = 6, D = 3; GKM RBF kernel) and ran an additional
12 iterations of the model varying only the random number seed for cross-validation.

4.6.7

SVM Model Parameter Search
To determining the effect of tuning the SVM misclassification cost and radial

basis function radius parameters, we trained 62 additional five-fold cross-validation
models and examined the results in terms of AUROC, AUPRC, and AUC Sum.
We varied the misclassification cost parameter by powers of ten and the RBF radius parameter by powers of two, which allowed us to include γ = 2 and C = 10
as recommended by the LSGKM author [Lee, 2016]. Our search space was γ ∈
{0.0625, 0.125, 0.25, 0.5, 1.0, 2, 4, 8, 16} and C ∈ {0.001, 0.01, 0.1, 1.0, 10, 100, 1000}.
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We examined preliminary results during model training and noted that values
of γ greater than 4 and less than 1 performed poorly. As a result, we canceled several
cross-validations that were displaying an unacceptably-long training time: C = 1000,
γ = 8; C = 1000, γ = 16; C = 100, γ = 8; C = 100, γ = 0.125; and C = 1.0, γ = 16.

4.6.8

Selection and Evaluation of Final Whole-Genome Model Parameters
From the results of the γ and C parameter grid search described in Sec-

tion 4.6.7, we selected the final parameters for training LSGKM on Caco-2 strong
enhancers: GKM + RBF kernel with L = 10, K = 6, D = 3, C = 10, and γ = 4.
To determine if these parameters were effective across cell types, we trained and
cross-validated two additional models using the Calu-3 and PANC-1 strong enhancer
sets. Instead of performing the lengthy grid search in each cell type, we chose as a
metric for success improvement in the Calu-3, and PANC-1 AUCROC and AUPRC
compared to the C = 1.0 and γ = 2.0 model results from Section 4.6.5.
After selection of the final model parameters, we trained all models of interest
(A549, Caco-2, Calu-3, and PANC-1) with the optimized parameters and without
cross-validation (i.e., training on the full data set instead of four-fifths of the data
set). We used each of these four final models to score the each of the four held-out test
sets to evaluate the models’ performance within and between cell-types, organizing
the results into a matrices of AUROC and AUPRC values which should indicate
real-world model performance.
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4.6.9

DeLong’s Test for Correlated AUROC
We used DeLong’s Test [Delong and Carolina, 1988] to determine whether

or not observed differences in AUROC were statistically significant. Primarily, we
applied the test to compare the test-set-performance of our final optimized models
(Section 4.6.8) with models trained (without cross-validation) using the default LSGKM parameters (L = 11, K = 6, D = 3, WGKM Kernel). We used DeLong’s test
as implemented in the Daim R package [Potapov et al., 2013], within a custom R
script to parse the LSGKM prediction output. We made comparisons within all four
cell types for which we isolated test sets: Caco-2, Calu-3, PANC-1, and A549.
We also applied DeLong’s test retrospectively to examine the statistical significance of selected intermediate models from our biological parameter search (Section 4.6.5), our modeling parameter search (Section 4.6.7), and our test of the AUROC
and AUPRC precision (Section 4.6.6). In order to apply DeLong’s test to the crossvalidation outputs, which contain the results from five models trained on different
subsets of the input data, we isolated the first group (out of five) of cross-validation
results. We do not present full results of these tests, as we did not use DeLong’s significance as a model-selection criterion, nor did we examine the significance of these
intermediate models in a consistent and unbiased manner. However, we do note a few
interesting results that give us confidence that DeLong’s test provides useful information for AUROC evaluation and that our intermediate model-selection choices were
statistically valid. We observed p-values ranging from clearly non-significant (p-values
on the order of 0.5 for models changing only the cross-validation random seed), to
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moderately significant (p-values on the order of 0.01 for models with slightly-varying
fine-tuning parameters), to highly significant (p-values on the order of 1 × 10−16 for
models with fundamentally different biological parameters).

4.6.10

CFTR TAD Parameter Search
In an attempt to create a CFTR-enhancer-specific classifier, we trained the

LSGKM model on the Strong CFTR TAD candidate enhancer set and the Putative
CFTR TAD candidate enhancer set. As these sets were orders of magnitude smaller
than the whole genome sets, a complete five-fold cross-validation run completed within
a few minutes, as opposed to hours or days. This allowed us to pursue a broad search
of parameters and kernels, without the need to successively narrow the parameter
search space using the step-wise optimization approach described previously.
Initial tests with the GKM kernel and typical values of K and L indicated
poor results, often returning an AUROC near 0.5, i.e. no better classification than
a random guess. In spite of this, we performed over 1000 cross-validation runs
varying a number of parameters: 8 ≤ L ≤ 12, 5 ≤ K ≤ (L − 3) ≤ 7, and
C = 0.0001, 0.001, 0.01, 0.1, 1.0, 10. As in Section 4.6.5, we held D = 3 constant;
for this search, we chose the weighted GKM radial basis function (WGKM RBF)
kernel, suspecting that the center-weighting of the kernel might help condition the
longer input sequences that did not undergo DNase filtration. Furthermore, we ran a
number of models using ten-fold cross-validation instead of five-fold cross-validation
and using a more stringent error threshold ( = 1 × 10−5 , as opposed to  = 1 × 10−3 )
for determining convergence.
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4.7

Enhancer Analysis with gkm-SVM

We performed an initial, exploratory analysis of the gapped k-mer SVM scores
by scoring the merged, cell-type-specific segmentations (for A549, Calu-3, and Caco-2)
of the CFTR TAD with their corresponding final, optimized SVM models. We sought
to understand which of the IDEAS-identified enhancer regions had the strongest
sequence-based enhancer signature, as opposed to the epigenetic signature identified by IDEAS. However, only a few segments within the CFTR TAD showed even a
weakly-positive gkm-SVM score. Table 4.18 shows all positive-scoring segments from
the CFTR TAD and, for comparison, the three lowest-scoring.

Table 4.18: Positive-Scoring vs. Highest-Negative-Scoring IDEAS Enh Regions
IDEAS Enhancer Region

gkmSVM Enhancer Score

Cell Type

hg19
hg19
hg19
. . .
hg19
hg19
hg19

0.436842
0.166311
0.118704
. . .
-1.85522
-1.91134
-2.02918

A549
A549
Caco-2
. . .
Calu-3
A549
Calu-3

chr7 117285200 117286400 +
chr7 116909200 116910800 +
chr7 117212800 117213800 +
chr7 117212000 117212400 +
chr7 117610800 117611600 +
chr7 116996800 116997000 +

Next, we used a custom Python script to generate the 799,975 possible 25 bp
sliding windows across the CFTR TAD and computed the gkm-SVM scores in Caco2, Calu-3, and A549. (We briefly examined scoring 100 bp sliding windows with the
Caco-2 model; however, we ultimately chose 25 bp sliding windows in order to focus
on the smaller-scale sequence-specific behavior, since we had already interrogated
the hundreds-of-bp scale using IDEAS.) As we observed a much richer set of results
using the 25 bp sliding windows, with thousands of positive-scoring fragments, we
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proceeded to select the top-fifth percentile of positive scores resulting from each cell
type’s model. We merged the contiguous segments, averaged their scores, and ranked
the resulting merged windows based on gkm-SVM score. Selection of the top-fifth
percentile and ranking of resulting windows was done using R; merging and averaging
contiguous regions required bedtools merge. To compare to the IDEAS output, we
used bedtools to intersect the high-gkmSVM-scoring sets with the respective strong
enhancer regions identified by IDEAS and visualized all results across the TAD using
IGV.

4.8

Variant Analysis with DeltaSVM

We used the DeltaSVM method to predict which observed human genetic
variants may lead to a gain or loss of enhancer function as predicted by our final, celltype-specific Gapped k-mer SVM models. We obtained variants from the Genome
Aggregation Database (gnomAD) project and the Clinical and Functional Translation
of CFTR (CFTR2) database, used DeltaSVM to score each variant, and examined
various subsets of the most significant scores. We treat DeltaSVM scores from different cell types as separate, independent observations, which expands our data set by
a factor of four to 250,688 variant scores from gnomAD and 1,072 from CFTR2.

4.8.1

Variant Data Collection and Pre-Processing
We downloaded the chromosome 7 whole genome Variant Call Format (VCF)

file from the gnomAD database [Lek et al., 2016], which describes the whole-genome
variation observed in 15,496 unrelated individuals. We did not add the exome data
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from gnomAD (123,136 individuals), as this would have biased our variant counts
toward protein-coding regions, and as our primary interest is in Enhancers, which are
generally intronic or intergenic. We isolated the 62,673 variants within the CFTR
TAD using bcftools.
To study Cystic Fibrosis-specific variation, we downloaded the 17 March 2017
list of variants from the CFTR2, which contains the allele frequency, variant identifiers, and phenotypic consequence (CF-causing, Non-CF-causing, varying consequence, and unknown significance) of 281 variants in the CFTR gene. We selected the
240 variants with dbSNP identifiers (rsIDs) for further analysis. Using dbSNP’s batch
query interface, we obtained the variants in VCF format. The dbSNP VCF was based
on the hg38 reference genome and represented insertions and deletions (indels) by a
hyphen in the reference or alternate columns, respectively. To ensure compatibility
with our downstream processing, we wrote a custom Python script to re-represent
all indels at one position to the left, so that at least one base would be present in
the reference and alternate columns. Then we used bcftools norm [Danecek et al.,
2011] to left-align and normalize all indel variants and converted the coordinates to
the hg19 reference using CrossMap [Zhao et al., 2014] and the appropriate lift-over
file from the UCSC Genome Browser.

4.8.2

DeltaSVM Scoring and Analysis
To score the CFTR TAD variants, we first convert them into a reference and

alternate FASTA files, containing the DNA sequences to be scored. We wrote a
custom Python script to print the appropriate reference and alternate bases such
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that each sequence includes (L − 1) bases of reference sequence before and at most
(L − 1) bases after the variant. This resulted in an equal length of (2L − 1) for each
sequence, and required that we discard any insertions or deletions greater than or
equal to L base pairs. For example, to construct the alternate FASTA sequence with
L = 10 and a single-nucleotide variation (SNV), we retain 9 bp of reference sequence
before and 9 bp of reference sequence after the variant sequence; with a three bp
deletion we retain 9 bp of reference sequence before and 9 bp of reference sequence
after the variant sequence; for a three bp insertion, we retain 9 bp of reference sequence
before and 6 bp of reference sequence after the variant sequence. To construct the
matching reference FASTA sequence, we print the variant’s reference base(s) instead
of the alternate base(s) and swap the retention pattern for insertions and deletions,
which results in reference and alternate sequences of equal length centered around
the variant’s position. In this example, the total length of each reference or alternate
segment is 19 bp, and each may be broken down into a set of 20 partially-overlapping
10-mers.
After creating the reference and alternate FASTA pairs from the gnomAD
and CFTR2 VCFs, we used the DeltaSVM PERL script to generate variant scores;
for each cell type (A549, Caco-2, Calu-3, and PANC-1) we scored gnomAD using
both the default and final optimized gkm-SVM models and scored CFTR2 using the
optimized models. For the remaining analysis, we treated each type of score on a
variant as a unique observation, for a total of 250,692 data points from gnomAD and
960 from CFTR2, with a few dozen variants common to both sets.
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When using the default models, which are based on 11-mers, we could compute
the scores based on 21 bp sequences and score indels up to 10 bp long; however,
we primarily computed and analyzed the default scores on the same FASTA source
(19 bp segments) as the optimized (10-mer-based) scores to ensure a fair comparison
between the two sets. To verify that we were making a fair comparison between the
10-mer-based and 11-mer-based models, we computed the 21 bp FASTA segments
that would best match to the 11-mer-based default models and scored both the 19 bp
and 21 bp variants under both default and optimized models for A549. Figure 4.3
demonstrates that the differences between the L = 10 and L = 11 score distributions
are not dependent on whether the FASTA files were generated as 19-mers (to take
advantage of a 10-mer model) or as 21-mers (to take advantage of an 11-mer model).
After scoring, we used bcftools to annotate the gnomAD VCF with per-celltype variant scores, DNase accessibility regions (as described in Section 4.5.2), broadcategory IDEAS labels (see Table 4.7), and IDEAS region beginning and end coordinates; we then wrote a custom Python script to extract the data and format it for
analysis in R. To prepare the CFTR2 data for analysis, we imported it into R and
used tools from the dplyr module to join the DeltaSVM scores with the corresponding CFTR2 data. As dbSNP included other variants seen at the same positions as
variants in the CFTR2 database, this necessitated a pruning step where we removed
dbSNP variants whose reference and alternate bases did not match the CFTR2 variant
descriptions (cDNA names).
Finally, we qualitatively and quantitatively examined the properties of the
variant scores using common R libraries such as dplyr, tidyr, and ggplot2. We ana83
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Figure 4.3: Comparison of L = 10 and L = 11 scores on matching and opposite
FASTA sets.

lyzed the relationships between multiple variables in an exploratory fashion, focusing
on DeltaSVM scores as a function of allele frequencies, variant positions, cell types,
IDEAS states, and DNase accessibility.
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CHAPTER 5

RESULTS

5.1

Overview

In order to identify and investigate candidate enhancers around CFTR, we created an analysis pipeline that leverages the Integrative and Discriminative Epigenome
Annotation System (IDEAS) genome segmentation model to identify enhancer regions, the Gapped K-mer Support Vector Machine (gkm-SVM) classifier to narrow
those regions based on DNA sequence, and the DeltaSVM scoring model to predict how observed human DNA sequence variants may modulate these predicted enhancers. We added epithelial cell epigenetic data for CFTR-relevant cell lines (A549,
Caco-2, Calu-3, PANC-1) to IDEAS, which resulted in cell-type specific predictions
of enhancer regions. Furthermore, we believe the additional data improve the IDEAS
segmentations of previously-published cell types. Using the predicted enhancer regions, we trained and optimized cell-type-specific gkm-SVM classification models to
recognize the DNA sequence patterns of the potential enhancers, and demonstrate
that our step-wise optimization process results in a small-but-significant increase in
the models’ discriminative power. We then used the gkm-SVM models to identify
and rank potential enhancers on a finer scale than the IDEAS model. Next, we use
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Figure 5.1: Overview of Enhancer Analysis Pipeline

the gkm-SVM models to calculate DeltaSVM scores, which predict the variant’s cumulative effect on the enhancer-related sequence motifs, for 62,673 observed variants
in the CFTR Topologically-Associating Domain (TAD) from the Genome Aggregation Database (gnomAD) project and 240 curated, Cystic-Fibrosis-implicated variants from the Clinical and Functional Translation of CFTR (CFTR2) database. We
demonstrate that our optimized models improve characteristics of the variant scores,
appreciably change the set of top-scoring variants, and increase their positional clustering within the TAD. Finally, we devise a method to use DeltaSVM scores and other
relevant information to filter the variant list down to a high-interest subset which we
believe will be a fruitful source for future wet-lab analyses. A conceptual summary
of this process is presented in Figure 5.1
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5.2

IDEAS Segmentation With Ten Cell Types

To identify broad-scale candidate enhancer regions, we selected the Integrative and Discriminative Epigenome Annotation System (IDEAS) genome segmentation model due to its ability to learn, in the author’s words, the “local epigenetic
landscape” at given genomic position, to use this information to cluster different
cell-types by their epigenetic similarity, and then combine the position-specific and
cluster-specific information to generate cell-type-specific predictions of the functional
characteristics of each genomic locus. We added epigenetic data from the epithelial
cell lines A549, Caco-2, Calu-3, and PANC-1 to increase the model’s ability to predict
cis-regulatory regions relevant to gene expression in epithelial cells, with particular interest in enhancers that may regulate CFTR. We demonstrated that our 10-Cell-Type
IDEAS model produces cell-type-specific segmentations around the CFTR locus, that
it produces a stronger signal for enhancers genome-wide, and that it predicts highly
cell-type-specific enhancers in Caco-2, Calu-3, and PANC-1.

5.2.1

IDEAS Segmentations Recapitulate CFTR Expression Differences
We generated genome annotation tracks for the ten cell-type-specific IDEAS

segmentations, using a similar color scheme to the original IDEAS36 tracks. Figure 5.2
shows the ten tracks ordered with the highest-CFTR-expressing cells at the top and
lowest-CFTR-expressing at the bottom. Examination of the segmentations in light
of the CFTR expression data presented in Table 4.3 demonstrates that our IDEAS
model recapitulates the relative expression of CFTR. In the top two cells showing
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Figure 5.2: 10-Cell IDEAS Segmentations of CFTR.

high CFTR expression, we note numerous signals in green throughout the gene body,
which are associated with active transcription (Elon, Gen3, Gen5, Pol2, etc.); at
the beginning of the gene, we see strong signals for the transcription start site and
promoter (red). In the cell types with moderate or low CFTR expression, we see
instead a less-active poised promoter signal (magenta) at the beginning of the gene,
often flanked by repressed regions (gray). Likewise, throughout the gene body we see
the active transcription signals replaced with longer segments belonging to the Low
and Repressed states; however, we note that in the moderate-expressing (GM12878
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Figure 5.3: 10-Cell IDEAS Segmentations of POLR2A.

and A549) and and low-expressing (h1-hESC and HeLa-S3) cells there is a greater
proportion of enhancer states (yellow) than in the cells with slight or negligible CFTR
expression (K562, PANC-1, HepG2, and HUVEC).
In contrast, Figure 5.3 shows the segmentation around the constitutivelyexpressed housekeeping gene POLR2A, which encodes part of the RNA Polymerase
II complex and is essential for the function of all cell types. In this gene, we observe
a remarkably consistent segmentation in each cell type, with strong signals for the
transcription start site, active gene body, and relatively-inactive intergenic regions.
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5.2.2

Additional Cell-Type Data Increases IDEAS Identification of Enhancers
Since IDEAS jointly models the probability of the observed data for all cell-

types, we next ask if the additional training data for A549, Caco-2, Calu-3 and
PANC-1 makes the model better or worse. Since we lack a genome-wide ground truth
segmentation, we cannot directly assess whether or not the segmentation accuracy
improves; however, we can compare the characteristics of our states of interest between
the original IDEAS36 model and 10-Cell IDEAS model.

Table 5.1: 10-Cell IDEAS Whole Genome Composition (By Length)
Calu-3 Caco-2 GM12878 A549 H1-hESC HeLa-S3 K562 PANC-1 HepG2 HUVEC
Enhancer
4%
Promotor
15%
Repressed
15%
Gene Body 17%
Open Chrom 4%
CTCF
1%
Low
33%
Blank / Excl 13%

7%
1%
18%
17%
4%
1%
39%
13%

10%
1%
21%
10%
3%
1%
41%
13%

10%
1%
19%
10%
4%
1%
41%
13%

10%
2%
18%
11%
4%
1%
41%
13%

9%
22%
0%
17%
2%
9%
27%
13%

8%
1%
21%
10%
3%
1%
42%
14%

8%
1%
20%
11%
3%
1%
42%
13%

8%
1%
20%
11%
4%
1%
41%
13%

10%
1%
21%
10%
3%
1%
41%
13%

For each 10-Cell IDEAS and IDEAS36 segmentation, we calculated the lengths
and counts of resulting genome states and grouped the states into broad categories for
consistent comparison between our 10-Cell IDEAS model and the IDEAS 36 model.
Table 5.1 shows the overall state composition across the entire genome in each cell
type under the 10-Cell IDEAS model. Table 5.2 summarizes the average change in
the predicted functional composition of the genome as a result of the additional data
added to the 10-Cell IDEAS model. The averages are a calculated across the common
six cell types with segmentations from both the IDEAS36 and 10-Cell IDEAS models.
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We note slight increases in most state categories at the expense of the Open Chromatin
states and the Repressed states. The reduction in the amount of the genome assigned
to Open Chromatin regions may indicate an increase in information content in the
resulting segmentation; while regions of open chromatin are functional areas of the
genome, this category is less informative than other IDEAS states associated with
functionally active regions, such as Enhancer, Promotor, or Gene Body regions.

Table 5.2: Average Change In Predicted Genome Composition (By Length)
State
Enhancer
Promotor
Repressed
Gene Body
Open Chromatin
CTCF
Low
Blank/Excluded

IDEAS36

10-Cell IDEAS

Difference

8.4%
2.0%
22.9%
9.3%
7.7%
1.0%
36.3%
12.3%

9.3%
4.8%
17.0%
11.5%
3.1%
2.4%
38.7%
13.2%

0.9%
2.8%
-5.9%
2.2%
-4.6%
1.4%
2.3%
0.9%

Similarly, Table 5.3 shows the average change from IDEAS36 to 10-Cell IDEAS
in terms of segment counts and average segment lengths. In this table, as in Table 5.2,
we observe a small but significant increase in predicted enhancer regions; we note
that, while the average enhancer region count increases, the average length of the
enhancer segments does not change, which indicates that the increase in count is due
to identification of new predicted enhancers, as opposed to breaking enhancer regions
up into smaller segments. (In contrast, the Low regions seem occasionally to have
been fragmented into smaller sections, given the significant increase in segment count
and decrease in segment length.)
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Table 5.3: Average Change in Whole Genome Segment Counts and Average Length
State

Change in Count

Change in Length

2,627
95,926
-330,966
-3,666
-142,293
8,142
407,955

0
80
13
-45
-111
101
-4,055

Enhancer
Promotor
Repressed
Gene Body
Open Chromatin
CTCF
Low

5.2.3

10-Cell IDEAS Segmentation Identifies Fewer, Higher-Quality Enhancers Within the CFTR TAD
To continue our examination of the change in enhancer-state characteristics as

a result of the data we added to the IDEAS model, we next focus specifically on the
CFTR TAD. Though we were surprised to observe fewer enhancer segments in this
region, we believe the additional data in fact leads to higher-quality enhancer calls
around CFTR.
Table 5.4: 10-Cell IDEAS CFTR TAD Genome Composition (By Length)
Calu-3 Caco-2 GM12878 A549 H1-hESC HeLa-S3 K562 PANC-1 HepG2 HUVEC
CFTR Expression High

High

Mod.

Mod. Low

Low

Neg. Neg.

Neg.

Neg.

Enhancer
Promotor
Repressed
Gene Body
Open Chromatin
CTCF
Low
Blank / Excluded

7%
1%
28%
22%
2%
2%
38%
1%

7%
1%
37%
3%
1%
1%
48%
2%

9%
1%
35%
3%
2%
1%
47%
1%

13%
0%
33%
3%
1%
2%
46%
1%

7%
0%
35%
3%
1%
2%
50%
2%

2%
0%
40%
3%
1%
1%
51%
2%

2%
0%
40%
3%
1%
1%
51%
2%

8%
17%
21%
27%
1%
1%
24%
1%

13%
1%
26%
7%
2%
2%
48%
1%

5%
1%
37%
3%
1%
2%
51%
1%

Table 5.5 and Table 5.6 again show the cross-cell average changes in, respectively, predicted genome composition and segment counts and average lengths. Similar to the whole-genome results (Table 5.2 and Table 5.3), we again observe a decrease
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in Repressed and Open Chromatin states and slight increase in Gene Body states.
Unsurprisingly, the more-rare Promotor, CTCF, and Blank/Excluded states show
very little change when looking only at a megabase-sized window of the genome. Unlike the whole genome results, we observe a notable decrease in the Enhancer state
and a very significant increase in the Low state.

Table 5.5: Average Change in Predicted CFTR TAD Composition (By Length)
State
Enhancer
Promotor
Repressed
Gene Body
Open Chromatin
CTCF
Low
Blank/Excluded

IDEAS36

10-Cell IDEAS

Difference

10.1%
0.6%
44.2%
3.5%
3.5%
1.8%
35.2%
1.1%

8.0%
0.6%
34.8%
3.9%
1.0%
1.6%
48.6%
1.5%

-2.1%
0.0%
-9.4%
0.4%
-2.4%
-0.2%
13.4%
0.4%

Table 5.6: Average Change in CFTR TAD Segment Counts and Average Length
State
Enhancer
Promotor
Repressed
Gene Body
Open Chrom
CTCF
Low

Change in Count

Change in Length

-32
0
-139
-7
-30
-13
104

77
88
54
711
-134
89
43

A reduction in Enhancer-associated states around CFTR may at first appear
to be a counterintuitive or discouraging result, given that the overall goal of our
analysis is to discover candidate enhancers around CFTR; however, this may instead
represent a reduction in segmentation noise and potentially-spurious enhancer states.
First, given that all models compared between IDEAS36 and 10-Cell IDEAS are the

93

Figure 5.4: Comparison of IDEAS36 and 10-Cell IDEAS Models Around CFTR

low-CFTR-expressing cells, it follows logically that the injection of higher-expression
signal from the Calu-3 and Caco-2 data might decrease the likelihood of calling local
Enhancers in the other, lower-expression cells. Second, in Table 5.6, we observe an
increase in the average length of Enhancer segments around CFTR (Enhancer length
was on average unchanged genome-wide), which may be another indicator of higherquality Enhancer calls in this region.
Despite the potentially-counterintuitive observation of fewer enhancers around
CFTR, other local observations give us overall confidence in the result. Congruent
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with our discussion in Section 5.2.1, we observe a correlation between the segmentation around CFTR and the gene’s relative expression; i.e. Gene Body states are
enriched and Repressed states depleted in highly-expressing cells compared to cells
without significant CFTR expression. Table 5.4 shows the overall state composition
around CFTR in each cell type for our 10-Cell IDEAS model. This may also be
observed in Figure 5.4, which shows six pairs of IDEAS segmentation tracks around
CFTR, comparing the IDEAS36 model (top of each pair) to its corresponding 10-Cell
IDEAS model (bottom of each pair). We note that each pair of segmentations shows
a quite similar sequence of features and are clearly more similar to one another than
they are to the segmentations for other cell-types; this indicates that the IDEAS
model is robust and gives similar results when re-run with additional training data.

5.2.4

IDEAS Identifies Highly Cell-Type-Specific Candidate Enhancers
Within the CFTR TAD
To examine whether potential CFTR enhancers in epithelial cells were cell-

type specific, we counted the overlapping 200 bp windows produced by our Caco-2,
Calu-3, and PANC-1 segmentations (10-Cell IDEAS) located within the CFTR TAD.
Figure 5.5 shows the results of counting all enhancer-related states, i.e. our putative
enhancer set, while Figure 5.6 shows the counts of only the strong enhancer states.
We observe that, in both cases, the majority of segments are seen only in a single
cell type, which further supports our observation that IDEAS produces a highly celltype-specific output.
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Figure 5.5: Venn Diagram of CFTR Putative Enhancers

5.3

Optimization of LSGKM Support Vector Machine Model

We next sought to model the specific DNA sequence motifs enriched in the
candidate enhancer regions that resulted from the IDEAS genome segmentation. For
each of our candidate cells of interest (A549, Caco-2, Calu-3, and PANC-1), we filtered
the predicted enhancer regions by overlapping with DNase hypersensitivity peaks and
used the result to train a sequence classifier to discriminate enhancer sequences from
random genomic sequences. We used the Large Scale Gapped K-mer (LSGKM) implementation of Gapped K-Mer Support Vector Machine (gkm-SVM), for which we
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Figure 5.6: Venn Diagram of CFTR Strong Enhancers

performed an extensive parameter search. In order to avoid a lengthy, exhaustive
search of parameters, we designed a biologically-guided, stepwise parameter search
heuristic under the hypothesis that model parameters dealing with the underlying,
biophysical phenomena could be optimized independently from the parameters dealing with the SVM feature representation and separation. We term these sets of
parameters biological parameters and modeling parameters, respectively.
Using K562 enhancers predicted by IDEAS36 as a preliminary dataset, we
explored the majority of the parameter space for biophysical characteristics: L, the

97

overall motif length or word length; K, the number of informative positions within the
motif; and D, the maximum allowed number of mismatches between motifs. We used
a combination of Area Under the Receiver Operating Characteristic Curve (AUROC)
and Area Under the Precision-Recall Curve (AUPRC) to rank candidate models based
on quality. Taking a subset of the initial K562 results, we examined the individual
effects of the choice of kernel transformation and a range of misclassification cost
penalties, C. We observe that neither choice of kernel nor the SVM C parameter
significantly changes the ranking of models, suggesting that separate optimization of
biological and modeling parameters is a reasonable heuristic for optimization.
Using the results in K562, we repeated the biological parameter search in our
enhancer sets for Caco-2, Calu-3, and PANC-1, but with a significantly reduced search
space. We observe that the biological parameters are not cell-type specific. Next, we
performed a final parameter search to optimize C (the misclassification cost) and γ
(width of the radial basis function transformation) and determine our final optimized
LSGKM parameters.
Using the optimized parameters, we trained SVM models on the full training
sets for Caco-2, Calu-3, PANC-1, and A549. We assessed the model’s likely realworld performance using the 10% of strong enhancer regions that we held aside as a
positive test set and compared our optimized results to models trained on the default
LSGKM parameters. Using DeLong’s test for difference in AUROC, we demonstrate
that our optimization process results in a small but statistically significant increase
of approximately 0.015 in AUROC.
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5.3.1

Initial K562 Parameter Search Suggests An Effective Smaller Search
Space
To perform an exploratory analysis on the performance of LSGKM, we used

IDEAS36-predicted enhancers in K562 cells as a positive training set and trained 163
five-fold cross-validation models. Table 5.7 summarizes the parameter search space.

Table 5.7: Initial K562 LSGKM Parameter Search Space
Parameter Description
L
K
D
C
Kernel

Lower Upper Parameter Parameter
Bound Bound Increment Count

Motif length (bases)
4
Number informative positions within motif
3
Maximum number of mismatched bases
0
Cost of misclassification during training (margin hardness) 1.0
GKM
N/A

12
12
3
1.0
N/A

+1
+1
+1
N/A
N/A

9
8
4
1
1

We observe significant variation across the range of the biological parameters:
the smallest values of L and K (e.g. 3-5) produce models which are effectively random
classifiers (AUROC ≈ 0.5); the largest length-parameter values produce models that
perform moderately well; and values close to the defaults perform best (L = 11,
K = 7 or L = 10, K = 6, depending on gkm-SVM implementation). Models with
mismatch parameter D = 2 or D = 3 clearly outperform those with D = 0 or D = 1.
Table 5.8 lists the top twenty models ranked by AUC Sum.
Figure 5.7, Figure 5.8, Figure 5.9, and Figure 5.10 are heat-maps showing
model performance based on AUROC, each at a different value of D. From these,
we note an interesting change in the performance pattern: by allowing sequence
mismatches, the gapped k-mer model appears better able to represent long sequences.
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Figure 5.7: Heatmap: K562 AUROC vs. Length Parameters (L, K, D = 0)

These preliminary results led us to hypothesize that implementing a reduced
parameter search space would be an effective and efficient means to discover a highperforming model in additional cell types.

5.3.2

Choice of Kernel Does Not Significantly Alter K562 Model Rankings
Next, we explored the effect of altering the kernel function used by LSGKM.

All alternate gapped k-mer SVM kernels are built off of the primary “GKM” kernel
which estimates the frequencies of possible L-mers based on the observed frequencies
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Figure 5.8: Heatmap: K562 AUROC vs. Length Parameters (L, K, D = 1)

of K-mers; however, the transformation into this L-mer count feature space may be
altered by center-weighting the sequence comparison (weighted GKM, WGKM) or by
using a radial basis function (GKM + RBF) to represent the data points. These two
transformations may also be combined (WGKM + RBF). The resulting parameter
search space is described in Table 5.9.
To determine whether changing the kernel induced significant changes into the
ranking of K562 models, we selected a subset of twelve models: two top-ranked models (“good”, AUROC ≈ 0.87), two moderately-ranked models “medium”, AUROC ≈
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Figure 5.9: Heatmap: K562 AUROC vs. Length Parameters (L, K, D = 2)

0.79), and two bottom-ranked models “poor”, AUROC ≈ 0.65). We cross-validated
these models under the three additional kernels and generated the AUC Sum ranking
shown in Table 5.10. From the rankings, we observed a small but consistent improvement from the various transformations and that the overall performance rankings are
unchanged by the transformations. That is, application of the a different kernel may
subtly change the performance of a given set of biological parameters, but appears
unlikely to turn a good model into a bad model, or vice versa. This result supports
(but, in isolation, cannot prove) our hypothesis that the kernel and modeling pa-
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Figure 5.10: Heatmap: K562 AUROC vs. Length Parameters (L, K, D = 3)

rameters may be optimized in a second, independent step after selection of length
parameters.
Within each set of length parameters, the top-ranking kernel varied between
GKM + RBF and WGKM + RBF; by inspection, the weighting transformation
appeared less beneficial in the good models as opposed to the medium or poor models.
As a result, we chose to move forward with the GKM + RBF transformation for
the remainder of the study. Other considerations included training time and study
complexity: we observed a significant increase in the mean training time and training
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Table 5.8: Top Twenty K562 LSGKM Models (Varying L, K, D)
L

K

D

AUROC

Rank AUROC

AUPRC

Rank AUPRC

AUC Sum

Rank AUC Sum

10
11
9
11
12
8
9
9
8
10
10
9
11
10
12
8
12
7
11
11

6
6
5
7
7
5
6
6
6
7
7
7
7
6
6
5
8
5
8
8

3
3
3
3
3
3
2
3
2
2
3
2
2
2
3
2
3
2
2
3

0.878
0.876
0.877
0.875
0.875
0.877
0.875
0.875
0.874
0.873
0.873
0.873
0.871
0.871
0.870
0.872
0.871
0.873
0.869
0.869

1
4
2
7
8
3
5
6
9
11
12
13
18
16
20
14
17
10
22
23

0.561
0.558
0.555
0.556
0.556
0.553
0.553
0.553
0.546
0.547
0.547
0.544
0.545
0.544
0.544
0.542
0.542
0.535
0.538
0.538

1
2
5
3
4
8
6
7
11
9
10
15
12
14
13
17
16
22
18
19

1.439
1.434
1.432
1.431
1.430
1.430
1.429
1.429
1.420
1.420
1.420
1.417
1.416
1.415
1.414
1.414
1.413
1.408
1.406
1.406

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Table 5.9: K562 LSGKM Kernel Search Space
Parameter Description
L, K
D
C
Kernel

Lower Upper Parameter Parameter
Bound Bound Increment Count

(7, 3), (9, 3), (10, 4), (12, 4), (10, 6), (11, 6)
N/A
Maximum number of mismatched bases
3
Cost of misclassification during training (margin hardness) 1.0
GKM, GKM + RBF, WGKM, WGKM + RBF
N/A

N/A
3
1.0
N/A

N/A
N/A
N/A
N/A

6
1
1
4

time variance with addition of the kernel transformations; furthermore, the weighting
function introduces two additional fine-tuning parameters, so the choice of WGKM
+ RBF would have dramatically increased the amount of time required to conduct a
thorough parameter search.
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Table 5.10: Ranking of Selected K562 Models Under Different Kernels
Model Rating L K Kernel
Good
Good
Good
Good
Good
Good
Good
Good
Medium
Medium
Medium
Medium
Medium
Medium
Medium
Medium
Poor
Poor
Poor
Poor
Poor
Poor
Poor
Poor

10
10
11
11
10
10
11
11
12
12
10
10
12
12
10
10
9
9
9
9
7
7
7
7

6
6
6
6
6
6
6
6
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3

GKM + RBF
WGKM + RBF
GKM + RBF
WGKM + RBF
WGKM
GKM
WGKM
GKM
WGKM + RBF
GKM + RBF
WGKM + RBF
GKM + RBF
WGKM
GKM
WGKM
GKM
WGKM + RBF
GKM + RBF
GKM
WGKM
WGKM + RBF
GKM + RBF
WGKM
GKM

ROC AUC PR AUC AUC Sum GKM Model Rank
0.8844
0.8837
0.8826
0.8820
0.8772
0.8778
0.8749
0.8756
0.8373
0.8384
0.8123
0.8109
0.7971
0.7950
0.7742
0.7727
0.6793
0.6797
0.6710
0.6693
0.6190
0.6186
0.6048
0.6024

0.5750
0.5751
0.5718
0.5721
0.5620
0.5608
0.5592
0.5579
0.4758
0.4699
0.4010
0.3985
0.3746
0.3662
0.3190
0.3166
0.1805
0.1797
0.1698
0.1685
0.1378
0.1370
0.1298
0.1287

1.4594
1.4587
1.4544
1.4541
1.4393
1.4386
1.4341
1.4335
1.3132
1.3083
1.2133
1.2094
1.1717
1.1612
1.0932
1.0893
0.8598
0.8594
0.8408
0.8378
0.7568
0.7556
0.7346
0.7311

1
1
2
2
1
1
2
2
3
3
4
4
3
3
4
4
5
5
5
5
6
6
6
6

Table 5.11: K562 C Parameter Search Space
Parameter Description
L, K
D
C
Kernel

5.3.3

Lower Upper Parameter Parameter
Bound Bound Increment Count

(7, 3), (9, 3), (10, 4), (12, 4), (10, 6), (11, 6)
N/A
Maximum number of mismatched bases
3
Cost of misclassification during training (margin hardness) 0.001
GKM + RBF
N/A

N/A
3
1000
N/A

N/A
N/A
∗10
N/A

6
1
7
1

Choice of Misclassification Cost Parameter Does Not Significantly
Alter K562 Model Rankings
To continue exploring our stepwise optimization paradigm, we next sought to

determine the effect of the modeling parameter C on our rankings of selected K562
models. This parameter controls the misclassification penalty during SVM training;
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higher values move closer to a hard-margin SVM, where no points are allowed to
remain on the wrong side of the feature-space hyperplane dividing the positive and
negative data points. Lower values result in a more permissive classifier and reduce
the model’s sensitivity to outliers in the data.
Using the same subset of good, medium, and poor K562 models, we varied C as
described in Table 5.11 and ranked the resulting 42 models based on AUC Sum. Once
again, we observe that altering this modeling parameter does not drastically alter
the model-quality ranking that was determined by the sequence-length parameters.
Table 5.12 shows the resulting ranking. We again take this result as support that
our stepwise optimization paradigm, which independently optimizes sequence-length
parameters from the SVM-specific parameters, is a reasonable approach to finding a
high-quality subset of models.
However, because the SVM-specific parameters, including C, essentially control the model’s response to shape of the training dataset within the feature-space,
we did not yet assume that the C = 1.0 parameter, which gave the top results in
Table 5.12, would necessarily remain optimal across other datasets.

5.3.4

Optimal Sequence-Length Parameters Are Not Significantly CellType Specific
To identify optimal sequence-length parameters in Caco-2, Calu-3, and PANC-

1, we searched a reduced portion of the parameter space for sequence length (L)
and number of informative positions within the sequence (K), which is described
in Table 5.13. Holding constant the model kernel (GKM + RBF) and maximum
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Table 5.12: Ranking of Selected K562 Models Under Different Misclassification Cost
(C) Parameters
Model Rating

L

K

C

ROC AUC

PR AUC

AUC Sum

C = 1.0 Model Rank

Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Good
Medium
Medium
Medium
Medium
Medium
Medium
Medium
Medium
Medium
Medium
Medium
Medium
Medium
Medium
Poor
Poor
Poor
Poor
Poor
Poor
Poor
Poor
Poor
Poor
Poor
Poor
Poor
Poor

10
11
10
10
11
11
10
11
10
10
10
11
11
11
12
12
12
12
10
10
10
10
12
12
10
12
10
10
9
9
9
9
9
9
9
7
7
7
7
7
7
7

6
6
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3

1.0
1.0
0.1
0.01
0.1
0.01
0.001
0.001
10
1000
100
10
1000
100
0.01
0.001
0.1
1.0
0.001
0.01
0.1
1.0
10
100
10
1000
100
1000
0.01
0.1
0.001
1.0
10
100
1000
0.1
0.01
1.0
0.001
10
100
1000

0.8844
0.8826
0.8839
0.8837
0.8823
0.8821
0.8782
0.8737
0.8769
0.8769
0.8769
0.8747
0.8746
0.8746
0.8543
0.8542
0.8535
0.8384
0.8419
0.8397
0.8387
0.8109
0.7671
0.7554
0.7539
0.7529
0.7506
0.7498
0.7139
0.7138
0.7105
0.6797
0.6726
0.6716
0.6693
0.6317
0.6289
0.6186
0.6142
0.6045
0.6029
0.6025

0.5750
0.5718
0.5705
0.5700
0.5681
0.5677
0.5610
0.5568
0.5512
0.5510
0.5510
0.5484
0.5482
0.5482
0.5111
0.5103
0.5104
0.4699
0.4616
0.4621
0.4618
0.3985
0.2990
0.2822
0.2759
0.2754
0.2643
0.2631
0.2179
0.2177
0.2139
0.1797
0.1718
0.1710
0.1695
0.1451
0.1437
0.1370
0.1354
0.1293
0.1285
0.1283

1.4594
1.4544
1.4544
1.4538
1.4504
1.4498
1.4392
1.4306
1.4281
1.4279
1.4279
1.4232
1.4228
1.4228
1.3654
1.3645
1.3639
1.3083
1.3035
1.3018
1.3005
1.2094
1.0660
1.0376
1.0297
1.0284
1.0149
1.0129
0.9318
0.9315
0.9245
0.8594
0.8444
0.8425
0.8387
0.7768
0.7727
0.7556
0.7496
0.7337
0.7314
0.7308

1
2
1
1
2
2
1
2
1
1
1
2
2
2
3
3
3
3
4
4
4
4
3
3
4
3
4
4
5
5
5
5
5
5
5
6
6
6
6
6
6
6
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Table 5.13: Caco-2, Calu-3, and PANC-1 LSGKM Parameter Search Space
Parameter Description
L
K
D
C
γ
Kernel

Lower Upper Parameter Parameter
Bound Bound Increment Count

Motif length (bases)
8
Number informative positions within motif
5
Maximum number of mismatched bases
3
Cost of misclassification during training (margin hardness) 1.0
RBF Radius
2
GKM + RBF
N/A

12
7
3
1.0
2
N/A

+1
+1
N/A
N/A
N/A
N/A

5
3
1
1
1
1

mismatch number (D = 3), we found sequence length of ten with six informative
positions to produce the top-ranked or close-second-ranked model in all three cell
types. Table 5.14 lists the top three results in each cell type, ranked according to the
sum of AUROC and AUPRC. We also note that other top-ranking results are generally
only one step away from the top model in parameter space, and that between the
datasets there are repeated parameter pairs. This shows a lack of cell-type specificity
with respect to the sequence-length parameters when training gapped k-mer SVM
models on candidate enhancer datasets.
For the remainder of the study, we chose the final sequence-length parameters of L = 10, K = 6, and D = 3. This set of parameters represents the top-ranked
models for Calu-3 and PANC-1 and the nearly-indistinguishably second-ranked model
for Caco-2. (Post-hoc analysis of statistical significance revealed that the top-ranked
and second-ranked Caco-2 models were not significantly different, having a DeLong
p-value of 0.74. Other cell types, however, did show statistically significant differences in top-ranked models.) We note that these parameters also produced the top
model for K562. Interestingly, this parameter set is the default parameters for the
R implementation of gkm-SVM and not far removed from the default parameters for
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the LSGKM implementation (L = 11, K = 7, all of which ranked in the top five
models for each cell type).

Table 5.14: Top-Ranking Length Parameters (GKM RBF Kernel, D = 3)

5.3.5

Cell Type

L

K

AUROC

AUPRC

AUC Sum

Caco-2
Caco-2
Caco-2

11
10
11

6
6
7

0.8926
0.8932
0.8926

0.6016
0.6008
0.6008

1.4940
1.4940
1.4930

Calu-3
Calu-3
Calu-3

10
11
12

6
6
6

0.8715
0.8712
0.8695

0.5482
0.5485
0.5474

1.4197
1.4197
1.4169

PANC-1
PANC-1
PANC-1

10
11
8

6
6
5

0.8651
0.8653
0.8649

0.6000
0.5994
0.5976

1.4650
1.4646
1.4625

AUROC and AUPRC Are Robust to Cross-Validation Shuffling
To better understand our preliminary results based on ranking by AUROC and

AUPRC and determine the level of precision with which we could make comparisons
between any two models, we investigated the inherent run-to-run variability as a
result of the cross-validation process. Using one of the top-scoring Caco-2 models
described in Section 5.3.4, we repeated the cross-validation using twelve additional
random seeds and compared the effect on our AUC metrics. Table 5.15 lists the
results of the additional cross-validation runs.
We observe that AUROC is quite stable under cross-validation shuffling, with
a sample standard deviation of 0.0003. This leads us to conclude that, when dealing
with inherently good models, a change in AUROC of 0.001 will be repeatable and
is unlikely to represent an artifact of a given sampling of the input data used in the
cross-validation process. AUPRC was somewhat less stable, with a sample standard
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deviation of 0.0007; AUPRC contributes a larger share of variability to the AUC Sum.
Overall, this result gave us confidence that our model rankings based on AUC Sum is
repeatable and that it can be meaningful to discuss the implications of a difference as
low as 0.001 in AUROC between any two models. Furthermore, in a post-hoc analysis,
we determined that the largest difference in AUROC was not statistically significant
(DeLong p-value 0.6738).

Table 5.15: Precision of AUROC and AUPRC
Random Seed

AUROC

AUPRC

AUC Sum

1
2
3
4
5
6
7
8
9
10
11
12
13

0.8931
0.8926
0.8930
0.8927
0.8932
0.8927
0.8933
0.8930
0.8928
0.8932
0.8932
0.8934
0.8935

0.6001
0.6001
0.6000
0.6007
0.6008
0.5998
0.6002
0.6010
0.6000
0.6012
0.6014
0.6013
0.6019

1.4932
1.4927
1.4930
1.4934
1.4941
1.4925
1.4935
1.4940
1.4929
1.4943
1.4946
1.4948
1.4954

Mean
Standard Deviation

0.8931
0.0003

0.6007
0.0007

1.4937
0.0009

However, we do note that these ROC standard deviations do not necessarily
hold for lower-quality models with significantly fewer training data; in Figure 5.11,
we see a ROC curve from a classifier built from the small CFTR Putative Enhancer
dataset in Caco-2, which shows a significant variability in AUROC even within a
single cross-validation run (see Section 4.6.10).
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Figure 5.11:
Dataset).

High-Variability ROC Curve (CFTR TAD Putative Enhancer
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Table 5.16: Caco-2 Model Parameter Search Space
Parameter Description
L, K, D
C
γ
Kernel

5.3.6

Lower Upper Parameter Parameter
Bound Bound Increment Count

(6, 10, 3)
N/A N/A
Cost of misclassification during training (margin hardness) 0.001 1000
RBF Radius
0.0625 16
GKM + RBF
N/A N/A

N/A
∗10
∗2
N/A

1
7
9
1

Optimization of RBF Radius and Misclassification Cost Result in
Small but Significant Improvements Across Cell Types
In order to fine-tune our models, we performed a grid search on the modeling

parameters C and γ, which control the response of the model to the shape of the
training data in the feature space. As described in Section 5.3.3, C controls the
cost of misclassification during training. The RBF parameter γ scales the similarity
score between any two points based on the distance between them in feature space;
larger values of γ shrink the radius such that distant points have a smaller influence
on each others’ classifications. As a result, larger values of γ more closely shape the
classification boundary to the shape of the data, while smaller values of γ more closely
resemble a linear classifier. We performed the grid search on the Caco-2 dataset on
the parameter space described in Table 5.16.
Table 5.17 lists the top-performing ten models resulting from the grid search.
We observe a slight enhancement to the model with a harder margin (C ≥ 10) and
γ = 4. In this case, it appears that the top three models are indistinguishable once
C is greater than ten; as a result, we chose to move forward using C = 10, opting for
the most conservative choice of C given the equal model effectiveness.
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Per our stepwise optimization procedure, the optimal training parameters we
selected for Caco-2 enhancers are the GKM + RBF kernel with L = 10, K = 6,
D = 3, C = 10, and γ = 4. Interestingly, C = 10 and γ = 4 are close to the
parameters recommended by Lee during the development of LSGKM (C = 10 and
γ = 2) [Lee, 2016].

Table 5.17: Caco-2 Model Parameter Grid Search
C

γ

AUROC

AUPRC

AUC Sum

1000
100
10
10
1000
100
1
0.001
0.1
0.01

4
4
4
2
2
2
2
4
2
2

0.8962
0.8962
0.8962
0.8948
0.8948
0.8948
0.8932
0.8899
0.8922
0.8921

0.6050
0.6050
0.6050
0.6032
0.6031
0.6031
0.6008
0.6000
0.5968
0.5966

1.5012
1.5012
1.5012
1.4980
1.4979
1.4979
1.4941
1.4898
1.4890
1.4887

We next sought to determine whether the fine-tuned parameters (C = 10 and
γ = 4) were appropriate for other cell types. We performed cross-validation using
these parameters for Calu-3 and PANC-1 and compared the results to runs described
in Section 5.3.4. We observe a consistent improvement in Calu-3 and PANC-1 when
using C = 10 and γ = 4 instead of C = 1.0 and γ = 2. Again, we cannot conclusively
prove that these results strictly maximize AUROC and AUPRC in these cell types;
however, consistent with our general stepwise optimization paradigm, we are confident
that this is a reasonable approach to determining a reproducible and close-to-optimal
set of parameters. Table 5.18 summarizes the improvements gained from the finetuning parameters.
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Table 5.18: Fine-Tuning Parameters Applied to Caco-2, Calu-3, and PANC-1

5.3.7

Cell Type

C

G

AUROC

AUPRC

AUC Sum

Caco-2
Caco-2

10
1

4
2

0.8962
0.8932

0.6050
0.6008

1.5012
1.4941

Calu-3
Calu-3

10
1

4
2

0.8762
0.8715

0.5537
0.5482

1.4299
1.4197

PANC-1
PANC-1

10
1

4
2

0.8707
0.8651

0.6082
0.6000

1.4789
1.4650

LSGKM Parameter Optimization Results In A Small But Statistically Significant Improvement In Model Performance

Table 5.19: LSGKM Default Parameters vs. Optimized Parameters
Parameter Description

Default Value Optimized Value

L
K
D
C
Kernel
γ
M
H

11
7
3
1.0
WGKM
N/A
50
50

Motif length (bases)
Number informative positions within motif
Maximum number of mismatched bases
Cost of misclassification during training (margin hardness)
Feature-Space Transformation
RBF Radius
Initial value of exponential decay weighting function
Half-life of exponential decay weighting function

10
6
3
10
GKM + RBF
4
N/A
N/A

Table 5.20: Final Model Performance on Test Sets
Cell Type

Positive Test Sequences

Negative Test Sequences

Test Set AUROC

Test Set AUPRC

Caco-2
Calu-3
PANC-1
A549

1,962
2,822
1,921
5,885

19,620
28,209
19,210
58,860

0.9010
0.8748
0.8707
0.9042

0.5897
0.5160
0.5862
0.5939

To evaluate the cumulative effect and statistical significance of our optimized
gapped k-mer SVM models of Caco-2, Calu-3, PANC-1, and A549 enhancers, we
trained optimized-parameter and default-parameter models on our test sets for each
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cell type. Optimized and default parameters are summarized in Table 5.19. The
positive test sets represent 10% of the strong-enhancer labeled regions identified by
IDEAS and were not used in previous parameter-selection steps; the negative test
sets are random genomic regions matched to the positive sequences in a 10:1 ratio.
Across all four cell types, we observed an average increase in AUROC of 0.015
and an average increase in AUPRC of 0.011; these results are summarized in Table 5.21. In all cases, the increase in AUROC was highly statistically significant
by DeLong’s test, the results of which are presented in Table 5.22. Figure 5.12,
Figure 5.13, Figure 5.14, and Figure 5.15 show the resulting receiver operating characteristic and precision-recall curves based on the classification of the test sets. All
indicate that the resulting models will perform well in identifying candidate enhancers
by their sequence characteristics.

Table 5.21: AUROC and AUPRC Improvements After LSGKM Parameter Optimization (Test Sets)
Cell Type

Model

AUROC

AUPRC

AUC Sum

Caco-2
Caco-2

Default
Optimized

0.8814
0.9010

0.5613
0.5897

1.4428
1.4907

Calu-3
Calu-3

Default
Optimized

0.8583
0.8748

0.5117
0.5160

1.3700
1.3908

PANC-1
PANC-1

Default
Optimized

0.8559
0.8707

0.5732
0.5862

1.4291
1.4568

A549
A549

Default
Optimized

0.8931
0.9042

0.5970
0.5939

1.4901
1.4981
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Caco-2 Strong Enhancer SVM Performance
L = 10, K = 6, D = 3, GKM + RBF Kernel, C = 10, g = 4.0
Positive Test Set: 1,962 Enh/Enh2 IDEAS Regions
Negative Test Set: 19,620 Matched Random Genomic Regions

Figure 5.12: Caco-2 ROC & P-R Curves

Calu-3 Strong Enhancer SVM Performance
L = 10, K = 6, D = 3, GKM + RBF Kernel, C = 10, g = 4.0
Positive Test Set: 2,822 Enh/Enh2 IDEAS Regions
Negative Test Set: 28,209 Matched Random Genomic Regions

Figure 5.13: Calu-3 ROC & P-R Curves
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PANC-1 Strong Enhancer SVM Performance
L = 10, K = 6, D = 3, GKM + RBF Kernel, C = 10, g = 4.0
Positive Test Set: 1,921 Enh/Enh2 IDEAS Regions
Negative Test Set: 19,210 Matched Random Genomic Regions

Figure 5.14: PANC-1 ROC & P-R Curves

A549 Strong Enhancer SVM Performance
L = 10, K = 6, D = 3, GKM + RBF Kernel, C = 10, g = 4.0
Positive Test Set: 5,885 Enh/Enh2 IDEAS Regions
Negative Test Set: 58,860 Matched Random Genomic Regions

Figure 5.15: A549 ROC & P-R Curves
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Table 5.22: Results of De Long’s Test For Significant AUROC Difference (Test Sets)
Cell Type

AUROC Difference

CI (lower)

CI (upper)

P Value

Correlation

Caco-2
Calu-3
PANC-1
A549

0.0195
0.0165
0.0148
0.0111

0.0153
0.0128
0.0098
0.0088

0.0238
0.0202
0.0198
0.0135

2.20E-16
2.20E-16
6.01E-09
2.20E-16

0.8610
0.8718
0.8729
0.8527

AUROC

Caco-2

Calu-3

PANC-1

A549

AUPRC

Caco-2

Calu-3

PANC-1

A549

Caco-2

0.901

0.816

0.789

0.841

Caco-2

0.590

0.428

0.378

0.449

Calu-3

0.818

0.875

0.853

0.875

Calu-3

0.404

0.516

0.577

0.577

PANC-1

0.761

0.834

0.871

0.876

PANC-1

0.294

0.474

0.586

0.576

A549

0.836

0.861

0.871

0.904

A549

0.447

0.575

0.651

0.594

Figure 5.16: Cross-Cell-Type Test Set Performance (AUROC & AUPRC)

5.3.8

Optimized Models Are Largely Cell-Type Specific
Using the final set of parameters, which are listed in Table 5.19, we trained

gapped k-mer support vector machine models using the data from the entire training
sets for Caco-2, Calu-3, A549, and PANC-1 enhancers. We used the four resulting
models to score all test sets and determine the cell-type specificity of each model.
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Figure 5.16 shows a matrix of the results; models are listed on the rows and test
sets on the columns. Bold text represents the highest value for a row, and italic text
represents the highest value for a column. The Caco-2 and Calu-3 models demonstrate
marked cell-type specificity, with AUPRC and AUROC significantly higher when
scoring matching test sets. On the basis of AUROC, the A549 model clearly performs
best on its own test set. However, the AUROC for PANC-1 indicates a somewhatbetter performance on the A549 test set; likewise, A549 performs better on the PANC1 sets than the other cross-type training sets. Given our previous observation that
AUPRC is a more variable measure, and the relatively small size of our test set, we
do not believe that this minor inconsistency invalidates the cell-type specificity of the
models.

5.3.9

The CFTR TAD Sets Are Too Small for Effective SVM Training

Table 5.23: CFTR TAD Parameter Search Space
Parameter Description
L
K
D
C
γ
M
H
Kernel


Lower
Bound

Motif length (bases)
8
Number informative positions within motif
5
Maximum number of mismatched bases
3
Cost of misclassification during training (margin hardness) 1 × 10−5
RBF Radius
2
Initial value of exponential decay weighting function
50
Half-life of exponential decay weighting function
50
WGKM + RBF
N/A
SVM minimum precision for end of training
1 × 10−5

Upper Parameter Parameter
Bound Increment Count
12
7
3
10
2
50
50
N/A
0.001

+1
+1
N/A
∗1
N/A
N/A
N/A
N/A
∗1000

5
3
1
7
1
N/A
N/A
1
2

We sought to apply our LSGKM optimization paradigm to two smaller training
sets: the set of predicted strong enhancer regions (Enh, Enh2) within the CFTR
TAD and the full set of predicted putative enhancer regions within the CFTR TAD.
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We trained and cross-validated over 1000 models within the parameter search space
described in Table 5.23; however, we were not able to train a successful model on
either of these small subsets of genomic regions. The majority of models had no
better performance than a random classifier (AUROC ≈ 0.5). A minority of models
showed an AUROC of approximately 0.65; however, within the cross-validation, the
individual ROC curves showed enormous variance, making it clear that the higher
AUROC was an artifact and that useful models would not result from this training
set. Neither a more stringent parameter for SVM convergence ( = 1 × 10−5 ) and
increasing the cross-validation to ten-fold was successful in narrowing the variance of
the resulting ROC and P-R curves. Figure 5.11 exemplifies the typical ROC output
of the CFTR-TAD-limited training.

5.4

gkm-SVM Identifies Fine-Scale Sequence Signatures of Enhancers
Within the CFTR TAD

We first sought to use the optimized gkm-SVM scores to characterize the
IDEAS-identified candidate enhancer regions within the CFTR TAD. We limited our
analysis to the top CFTR-expressing cells (A549, Caco-2, and Calu-3). Though the
majority of these regions were included in the gkm-SVM training data, we hypothesized that re-examining them on the basis of sequence characteristics could provide
a useful measure of the relative importance of each region and help identify the finescale (tens of base pairs) regions involved in enhancer activity.
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Figure 5.17: Ranked, Top-Scoring Enhancer Regions in CFTR TAD via gkm-SVM

We first scored all CFTR TAD candidate strong enhancers with the optimized
gkm-SVM models; however, as only three regions displayed a weakly-positive gkmSVM score, we determined this hundreds-of-base-pair-scale analysis to be unhelpful.
Instead, to examine fine-scale sequence features, we generated all 25 bp segments in a sliding window across the CFTR TAD and calculated their gkm-SVM
scores, yielding thousands of segments with DNA sequence signatures of the celltype-specific enhancers. Figure 5.17 shows the regions with top-fifth percentile of
positive gkm-SVM scores in each cell type. The merged regions in each cell type are
ranked by gkm-SVM score from low (bottom-rank, blue) to high (top-rank, red). The
figure also shows the IDEAS-identified enhancer regions and the intersection between

121

the two sets. We identified 119 segments ranging in size from 25 bp to 39 bp: 34 in
A549, 63 in Caco-2, and 23 in Calu-3.
We observe a very limited overlap between the gkm-SVM-identified and IDEASidentified enhancer regions. This could indicate that, though whole-genome and
CFTR TAD enhancers share identifiable patterns of chromatin modifications and
other epigenetic features, they are driven by differing sets of sequence features. However, it is also possible that this apparent difference may be an artifact of the differences in spacial resolution between the two models: the ChIP-seq and DNase-seq
data that drive IDEAS are inherently more spatially-spread than the discrete sequence
data (k-mer counts) that drive gkm-SVM. In either case, we believe that the identified
regions represent a potentially-fruitful target for further biochemical inquiry.

5.5

Enhancer Analysis with DeltaSVM

We isolated 62,673 observed variants in the CFTR TAD from the Genome
Aggregation Database (gnomAD) project, which includes the whole-genome sequence
variation observed in 15,496 unrelated individuals. For each variant, we calculated
four DeltaSVM scores based on our optimized sequence-signature models of A549,
Caco-2, Calu-3, and PANC-1 enhancers. The DeltaSVM score represents the difference in the sum of gkm-SVM 10-mer scores between the reference and alternate DNA
sequences around a given variant. To determine the effectiveness of our gkm-SVM
optimization, we also examine the set of DeltaSVM scores generated from gkm-SVM
models trained under default parameters. We demonstrate that our model optimization protocol alters the resulting set of high-scoring variants and improves our ability
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to use DeltaSVM scores to discriminate variants that potentially modulate enhancer
function around CFTR. We devise a filtration method based on DeltaSVM score and
DNase accessibility to generate a subset of variants most likely to have enhancermodifying activity. Finally, we examine the DeltaSVM scores of 240 curated variants from the Clinical and Functional Translation of CFTR (CFTR2) database and
determine a small subset of Cystic Fibrosis-causing variants which may also have
enhancer-modifying effects.

5.5.1

gkm-SVM Optimization Improves DeltaSVM Score Characteristics
To assess whether our gkm-SVM optimization significantly affected the re-

sulting DeltaSVM scores of variants, we examined the distributions of all defaultparameter DeltaSVM scores and optimized-parameter DeltaSVM scores, treating
scores from each of the four models (A549, Caco-2, Calu-3, and PANC-1) as independent observations. Then, we selected and compared subsets containing the
1,000 variants with the highest absolute value DeltaSVM scores. We observe tighter
distributions of DeltaSVM scores and increased positional clustering of high-scoring
variants under the optimized models. Approximately 16% of the top-scoring variants
change after model optimization.

5.5.1.1

Optimized DeltaSVM Scores Cluster Tightly Around Zero

Figure 5.18 compares the distribution of DeltaSVM scores across all variants,
separated by cell type and model type. We observe that the distributions for optimized models are more tightly clustered around zero, displaying higher kurtosis (26.3
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Effect of Model Optimization on CFTR TAD deltaSVM Scores
20

deltaSVM Score

10

cell
A549
Caco2

0

Calu3
Panc1
−10

−20
Default

Optimized

Model Type

Figure 5.18: Distributions of Optimized and Default DeltaSVM Scores

versus 14.2) and lower variance (standard deviation 1.59 versus 0.85). We believe this
represents a desirable characteristic for the DeltaSVM score, as a score that grades
more variants at or near zero will result in smaller sets of high-scoring variants for
further analysis. For example, if we select scores with an absolute value greater than
1.0 from a set of approximately 245,000 scores, the default DeltaSVM set returns
100,000 results, while the optimized DeltaSVM set returns 30,000 results. While we
do observe lower scores overall in the optimized-parameter sets, we note that the
value of the score does not have an intrinsic meaning, so this does not necessarily
result in a loss of information or capacity for discrimination.
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Default LSGKM Models

163

Optimized LSGKM Models

837

163

Figure 5.19: Thousand Top-Scoring Variants in Optimized and Default Models

5.5.1.2

Sixteen Percent of Highest-Magnitude Variant Scores Are Sensitive to Model Optimization

We observe that 16% of top-scoring variants change as a result of the gkm-SVM
optimizations. From each set of DeltaSVM scores, default-parameter and optimizedparameter, we selected a subset of the 1000 variants with the highest-magnitude
DeltaSVM scores. The majority of variants, 837, are common to both sets, leaving
163 variants unique to each set. Figure 5.19 illustrates with a Venn diagram.
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Position−Specificity of Optimized vs. Default Models

Variant Count per 10,000 bp

Top 1000 Variants by Absolute Value of deltaSVM

75

50

25

0
116800000

117000000

117200000

117400000

117600000

Position
Models Retreiving Variant:

Default & Optimized

Default Only

Optimized Only

Figure 5.20: Position-Specificity of Optimized vs. Default Models

5.5.1.3

Model Optimization Increases Position-Specificity of Highest-Magnitude
Variant Scores

In Figure 5.20, we demonstrate an increased positional clustering of highscoring variants when scored using the optimized models. Per-window counts of
the 837 variants shared between the two sets are shown in gray, while counts of
the 163 optimized-unique and default-unique variants are shown in blue and red,
respectively. We observe that many of the shared variants cluster at specific positions
across the TAD; this pattern is recapitulated often in the variants unique to the
optimized models, while the variants unique to the default models are more-uniformly
distributed within the TAD. This indicates an increased ability of the optimized
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CFTR TAD Variants: deltaSVM vs AF
All Variants

10

5

cell_type

deltaSVM

A549
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−5

−10

0.00
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0.75

1.00

gnomAD Allele Frequency

Figure 5.21: Comparison of Allele Frequency and DeltaSVM

models to recognize the clusters of individual transcription factor binding sites that
made up enhancers.

5.5.2

gnomAD Variants With Extreme DeltaSVM Scores Are More Rare
With Figure 5.21, we interrogate the relationship between DeltaSVM score

(optimized) and gnomAD allele frequency. We observe that the vast majority of
extreme DeltaSVM scores are present at very low allele frequencies. Furthermore,
there is also a slight bias toward potentially-enhancer-disrupting alleles at higher
frequency.
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CFTR TAD Variants Per IDEAS State Class
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Figure 5.22: Count of Extreme-Scoring Variants Per IDEAS Class

5.5.3

Creation of a Filtered Set of High-Interest gnomAD Variants
In order to generate a subset of high-priority variants for further wet-lab anal-

ysis, we examined only scores from variants in a DNase-hypersensitive region for the
matching cell-type, and then selected variants in the top-fifth or bottom-fifth percentile of all DeltaSVM scores. The combination of the DNase and DeltaSVM score
requirements filter the set of 250,668 DeltaSVM score observations to 119 high-interest
variant observations.
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5.5.3.1

Filtering by DNase-Accessibility Selects for Variants in Predicted
Regulatory Regions

Figure 5.22 shows the variant counts by cell type and IDEAS class. The
left panel (“FALSE”) shows the top-and-bottom-scoring variants lying outside of a
DNase hypersensitivity region, while the right panel (“TRUE”) shows the variants
lying inside those regions. We observe that the variants outside of the regions of
accessible chromatin are located largely in Low or Repressed states, while the few
variants in the accessible regions primarily found in Enhancer states. Therefore, in
addition to reducing the size of the variant set, filtering variants by DNase-accessible
regions successfully enriches for regulatory areas including enhancers, CTCF binding
sites, and promoters. With the addition of the high-magnitude DeltaSVM score
filter, we hypothesize the resulting set as the most likely to contribute to differential
expression of CFTR and propose these as the high-priority variants for further study.
However, we do note that the most extreme values of DeltaSVM scores are
not found within the DNase-accessible regions. Figure 5.23 compares the distributions of DeltaSVM scores inside (“TRUE”) and outside (“FALSE”) of those regions.
This may be an artifact of the small number of variants in DNase-accessible regions.
These variants may also merit investigation; however, as they are in closed chromatin
structures, they are significantly less likely to have a pronounced effect on TF binding.
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IDEAS State and DNase Accessibility vs. deltaSVM
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Figure 5.23: DeltaSVM Score Distributions Per IDEAS Class

5.5.3.2

High-Interest Variants Are Positionally Clustered Within the CFTR
TAD

We next examined the positional distribution of our high-priority variant
set described in Section 5.5.3.1. Figure 5.24 is a graph of variant position versus
DeltaSVM score and is overlaid with the genes making up the CFTR TAD. We
again note positional clustering (visible as vertical bands of points), particularly in
the negative DeltaSVM scores, which may indicate clusters of particularly important
TF-binding sites.
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Figure 5.24: High-Interest Variant Scores and Positions in CFTR TAD

5.5.4

A Small Minority of of CF-Causing Variants Could Modulate CFTR
Enhancer Activity
Finally, we examined the DeltaSVM scores of a curated set of 240 Cystic-

Fibrosis-implicated variants from the CFTR2 database. In Figure 5.25 we present
box plots of the scores, separated by variant consequence. We include the distribution
of all (unfiltered) gnomAD variants for comparison. Unknown-significance, varyingconsequence, and non-CF-causing distributions are fairly tightly-clustered around
zero and generally symmetric. Curiously, we observe wider, right-skewed distribu-
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tions of CF-causing variants, some of which are notable outliers based on DeltaSVM
score. We present a small selection of these variants in Table 5.24, which have been
selected based on exceeding the 1st or 99th percentile of gnomAD DeltaSVM scores.
We are particularly interested to observe extreme DeltaSVM scores on certain variants
which produce some amount of functional or partially-functional CFTR protein and
a more-mild Cystic Fibrosis phenotype. (A marker of phenotype severity, percentage
of patients with pancreatic insufficiency (PI) is listed in Table 5.24, with a higher
incidence of PI typically being associated with a more-severe (and more typical) CF
phenotype.) This may suggest a hypothesis in which the severity of these variants
that do not fully ablate protein production (including splicing variants, some missense variants, or nonsense variants occurring toward the end of the gene) is further
modulated by the gain or loss of an intragenic enhancer at the variant site.

Table 5.24: CF-Causing Variants With Extreme DeltaSVM Scores
Position

Ref. Alt. cDNA

117180272 G
117180272 G
117180272 G
117199710 G
117280015 C
117280015 C
117292959 C
117267795 AT
117227888 G
117144332 G
117251649 T
117251771 C
117235092 T
117282538 C

T
T
T
A
T
T
T
A
A
T
G
A
TA
A

Protein

% PI Determination Cell

c.988G>T
p.Gly330X
100% CF-causing
c.988G>T
p.Gly330X
100% CF-causing
c.988G>T
p.Gly330X
100% CF-causing
c.1584+1G>A No protein name 50% CF-causing
c.3718-2477C>T No protein name 33% CF-causing
c.3718-2477C>T No protein name 33% CF-causing
c.3937C>T
p.Gln1313X
100% CF-causing
c.3691delT
p.Ser1231ProfsX4 100% CF-causing
c.1679+1G>A No protein name 100% CF-causing
c.79G>T
p.Gly27X
100% CF-causing
c.3154T>G
p.Phe1052Val
15% Varying
c.3276C>A
p.Tyr1092X
99% CF-causing
c.2600 2601insA p.Val868SerfsX28 100% CF-causing
c.3764C>A
p.Ser1255X
80% CF-causing
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Figure 5.25: High-Interest Variant Scores and Positions in CFTR TAD
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CHAPTER 6

DISCUSSION

6.1

Biological Insights

Our construction of a pipeline combining the IDEAS genome segmentation
model, the gkm-SVM sequence classifier, and the DeltaSVM variant-scoring model
allowed us to integrate a voluminous and diverse set of biochemical and genomic data
into a set of concise metrics, which have generated insights and valuable hypothesis
regarding the regulation of the CFTR gene. Cystic Fibrosis, a Mendelian genetic
disorder caused by absence or dysfunction of the CFTR protein resulting in hyperviscous mucus secretion, shows a high degree of phenotypic variability both within
and between genotypes. We consider this variability in the context of differing levels of
expression of CFTR mRNA between individuals; furthermore, examination of CFTR
expression is also interesting due to it’s high variability between different tissues and
at different stages of human development. Ultimately, we seek to understand and
potentially modify this range of CFTR expression by discovering and characterizing
enhancers within the CFTR topologically associating domain (TAD) and the sequence
variants that may amplify or dampen their ability to increase CFTR expression. Our
gkm-SVM scores for genomic positions and the DeltaSVM scores for variant sequences
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represent predictions of enhancer identity. Examination of these scores allows us to
generate a short-list of regions and variants for future studies and provides biological
insights that will guide our work.
Given the scale of population-scale genomic datasets, a variant-filtering paradigm
is an essential component of any analysis seeking to link genetic variation with phenotypic consequences. Even when using massively parallel in-vitro molecular biology
techniques, it is clearly intractable to analyze each of the 62,673 variants observed
near CFTR in the Genome Aggregation Database (gnomAD); even with a filter based
on a single biochemical assay, such as location in a DNase hypersensitivity region in
one of our cell-types of interest (A549, Caco-2, Calu-3, or PANC-1), there are still
837 unique variants to examine. Our scoring pipeline allows this DNase-accessible set
to be reduced by 87% to 109 unique variants, which is much more tractable for individual or high-throughput analysis. Also, as a an ultimately sequence-based measure,
the gkm-SVM and DeltaSVM scores can provide information, and thus the ability to
filter, at a finer spatial resolution; as a continuous score (as opposed to a binary measurement such as overlap with a DNase hypersensitivity peak), the scores allow us to
control the stringency of the resulting filter, which means we can optimize the tradeoff between the size of the variant set (i.e., the resource expenditure for downstream
analyses) and the probability of information loss.
It is particularly interesting that DeltaSVM scores tend to become less extreme
with increasing allele frequency (Section 5.5.2). Given the variance and outliers in
CFTR expression observed across samples in the Genotype-Tissue Expression (GTEx)
database, a resulting simple hypothesis would posit that these expression differences
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could be driven by combinations of commonly-occurring, enhancer-modulating alleles; however, the bias we observe toward rare alleles in predicted enhancer-modulating
variants does not support that model. Instead, it would more strongly support a
model in which rare, potentially private variation drives significant difference in CFTR
expression, though common alleles with extreme DeltaSVM scores are not so depleted
as to make the common-variation model implausible. Though we cannot make conclusions on either hypothesis, our analysis does indicate that further experimental
investigation of this relationship is likely to be informative.
Our observation that a few Cystic Fibrosis-causing variants have DeltaSVM
of notable magnitude will give us cause to perform a more detailed analysis of these
variants in future studies. We hypothesize that the DeltaSVM score may explain a
fraction of unaccounted-for phenotypic variance between CF-causing variants which
should otherwise be similar, for example between two missense variants that affect
protein gating, or between two splicing variants that share similar biochemical effect on protein production. Such an inquiry could proceed via unbiased, data-first
analysis, such as multiple linear regression, though the relatively limited number of
well-characterized CF-causing variants may require manual curation of biochemicallysimilar variants.
Finally, the utility of our pipeline need not be confined to the study of CFTR
enhancers. We also plan to investigate its utility to a collaborating lab’s study of undiagnosed developmental delay and intellectual disability (DD/ID). Similarly to our
efforts to identify CFTR-expression-altering variants, their efforts to identify DD/IDcausing variants requires a variant filtering and prioritization strategy that distills a
136

wide range of data into a prediction of an individual variant’s capacity to be deleterious, though on a significantly larger scale, given the numerous genes associated
with DD/ID [Bowling et al., 2017, Kircher et al., 2014]. We hypothesize that our
cell-type-specific enhancer DeltaSVM scores, in concert with the other metrics and
filtering methods used by Bowling et al., may highlight variants worthy of further
investigation in the study of DD/ID.

6.2

Modeling Insights

In addition to the biological insights and hypothesis described in Section 6.1,
our results also yield significant insights into the use of genomic machine-learning
tools such as gkm-SVM and IDEAS. Foremost, we note the importance of leveraging
biology to guide the modeling process: had we not made repeated use of the DNase-seq
data to isolate sequences and variants present in open regions of chromatin, i.e. the
regions of DNA most commonly accessible to the cell’s transcriptional machinery, we
would have not had the computational resources to so thoroughly optimize the gkmSVM parameters, nor would we have been able to as easily create a set of prioritized
variants for future analysis. Similarly, knowledge of the underlying biology provides
a key sanity-check to the parameter-optimization results: repetition across cell types
of the optimum parameters for sequence length, gaps, and informative positions is
consistent with the field’s knowledge about individual transcription factors; had we
observed significant differences in parameters between the cell types, that would have
implied specific cell-to-cell changes in the underlying biology, which would need to be
examined for plausibility.
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We observed significant consistency between our optimal sequence-length parameters (word length L = 10, informative positions K = 6, allowed mismatches
D = 3) and the default parameters in the gkm-SVM implementations: these parameters match the R implementation and are close to the LSGKM implementation’s
default of L = 11 and K = 7. Importantly, this suggests that off-the-shelf use of
either implementation of gkm-SVM will perform sufficiently well for a variety of applications. Though our selection of modeling parameters (GKM kernel with radial
basis function transformation of radius γ = 4.0 and misclassification cost C = 10.0)
resulted in a statistically significant improvement in AUROC, we acknowledge that
the improvement was small and came at a cost of significant time required to optimize the models; fortunately, though the additional parameters are not guaranteed
to be optimal, the improvement appears to transfer across cell-type-specific sets of
input data, which suggests their re-use is appropriate for any future studies to model
IDEAS-identified predicted enhancer regions.
Our intuition is that any precise improvement in AUROC is a valuable improvement to any model operating at a genomic scale; when the model will be used
to make hundreds of thousands or millions of comparisons, small differences in performance will be magnified significantly. It is helpful to examine a few brief thought
experiments to quantify that intuition; we will consider the smallest improvement
in AUROC seen, 0.0111 (A549), in light of the fact that AUROC is interpretable
as the probability that a classifier will rank a randomly-selected condition-positive
item higher than a randomly-selected condition-negative item. Naively, and without
knowledge of the true number of condition-positive and condition-negative observa138

tions in our data sets, we may attempt to interpret this as a probability of improvement in a given score. By that metric, we might expect to see a improvement in 8,880
25 bp segment scores (Section 5.4) or 2,783 variant scores (Section 5.5). These numbers are compelling; however, instead of this rough approximation of the AUROC’s
probabilistic meaning, we can employ it more correctly by examining the make-up
of a DeltaSVM variant score. Recalling that the 10-mer based DeltaSVM score is a
composite of twenty comparisons of gkm-SVM scores between reference and alternate
sequence, we observe that the gkm-SVM AUROC describes the probability of a given
DeltaSVM component (i.e. a difference in scores) having the correct positive or negative direction. We may then calculate the probability of observing a DeltaSVM score
having all component scores in the correct direction: 0.104 with the default gkmSVM parameters and 0.133 with our optimized gkm-SVM parameters. This leads to
a more conservative expected count of 7,322 improved DeltaSVM observations. For
the most conservative count, we can examine informative DeltaSVM scores instead
of fully-correct DeltaSVM scores, defining an informative DeltaSVM score as one in
which more than half of component scores have the correct positive/negative direction. Each DeltaSVM score can then be modeled as a set of Bernoulli trials and
the expected fraction of informative scores calculated from the binomial distribution.
Under this model, we expect 99.990% of scores to be informative using the default
gkm-SVM parameters and 99.996% to be informative using the optimized gkm-SVM
parameters. While this leads to a less-impressive estimate of the count of expected
improved DeltaSVM scores (13 observations), it does give us significant confidence in
the DeltaSVM paradigm.
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We also note that the overall AUROC for each cell type (A549 > Caco-2 >
Calu-3 > PANC-1) mirrors the count of data types available for input to the IDEAS
segmentation (14 datasets for A549, 6 for Caco-2, 6 for Calu-3, and 5 for PANC-1).
While we cannot draw strong conclusions regarding this correlation, it does suggest
that input data may be the limiting factor in a model’s quality; at no point during
our analysis did we observe that sophisticated tuning of the SVM parameters change
our initial assessment of that model’s performance.

6.3

Limitations

We recognize several limitations of our analysis. In addition to it’s predictive,
not demonstrative, nature, it is important to keep in mind that our analysis is based
on data collected from immortalized human cell lines; while these cell lines have
produced numerous invaluable biological insights, they do not perfectly recapitulate
in-vivo cellular biology, as the majority used in our analysis are derived from cancerous
tissues. As a result, while our analysis can generate a number of useful hypotheses
regarding CFTR regulation in human tissues, significant follow-up will be required
to generate clinically actionable knowledge.
Though it is tempting to interpret our gkm-SVM and DeltaSVM scores as predictions of enhancer activity, this is not the case. We are measuring likelihood, based
on DNA sequence, of observing an enhancer. Predicting the strength of the enhancers
(i.e. the magnitude of increase in CFTR expression) would require consideration of
which transcription factors bind to the enhancers and the overall context of their interaction with biochemical signaling pathways; this would require either a different or
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expanded set of input data to IDEAS, or an additional predictive modeling paradigm
(possibly including RNA-seq data as a feature) to incorporate that information.
We also note that our results depend significantly on the DNase-seq datasets,
as we made repeated use of the datasets at all major stages of our analysis: generation
of the IDEAS segmentation, selection of the IDEAS-predicted enhancers for SVM
training, and the selection of high-interest variants based on DNase accessibility and
DeltaSVM score. As a result, the quality of these data will have a disproportionate
effect on the quality of our results; furthermore, we are significantly biased toward
presenting results located in these areas of the genome. (But, fundamentally, this
bias is acceptable as it is is concordant with the biological control mechanism.)

6.4

Future Work

In addition to a variety of laboratory-based and informatics-based analyses to
examine the observations and hypotheses discussed in Chapter 5, Section 6.1, and
Section 6.2, we suggest particular areas of our analysis that could benefit from additional refinement: IDEAS segmentation labeling, IDEAS parameter optimization,
and the gkm-SVM gap allowance parameter. One of the first stumbling blocks encountered in our analysis was the assignment of meaningful semantics to the states
resulting from the IDEAS segmentation (see Section 4.4.2); this was a particularly
time-consuming and potentially-subjective portion of our analysis. As a result, we
did not perform any optimization of the IDEAS parameters, as we doubted that a
manual label-assignment process would yield the consistency necessary to make comparisons across several model runs. Libbrecht et al. present a particularly compelling
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technique for ameliorating this concern: automated assignment of segmentation semantics via an additional machine learning step. They created a unified and concise
grammar of functional states and trained a random forest classifier to label each
segment based on the segments’ chromatin marks and enrichment in known genes
in comparison to existing, manually-annotated segmentations from ChromHMM and
Segway [Libbrecht et al., 2016,Ernst and Kellis, 2012,Hoffman et al., 2012]. Use of this
technique and accompanying software would allow us to assign semantics to multiple
IDEAS segmentations quickly and consistently, allowing us to explore optimization
of the IDEAS parameters. We hypothesize that optimization of the IDEAS segmentation could provide a powerful method to improve our results by conditioning the
input to the SVM training step; in particular, it would be interesting to examine the
prior concentration parameter, which affects the balance between position-specificity
and cell-type-specificity in the segmentations. With respect to the gkm-SVM optimization, we again note that we did not investigate the effect of allowing up to 4
mismatches (D = 4) within the sequence patterns. Though this would likely add
significantly to the training time for those models, it would be valuable to perform a
cursory search to ensure that this does not unexpectedly change the model’s response
to the other sequence-length parameters. Finally, despite the potential for improvements resulting from further tuning of the Hidden Markov Model (HMM) or Support
Vector Machine (SVM) models, and as we noted in Section 6.3, the most efficacious
way to improve our pipeline is likely to be a focus on completing or expanding the
set of input data.
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CHAPTER 7

CONCLUSION

Genes are controlled by multiple interconnected feedback systems that regulate when, where, and how much functional protein products are created from the
instructions they encode, and much remains to be elucidated about the regulation of
genes such as CFTR. Enhancers are DNA sequences to which transcription factors
bind and recruit cellular transcription machinery to nearby promoters, and as such
are a key component of the feedback networks that regulate gene expression at the
point of transcription of DNA into mRNA. Thus, discovery, characterization, and manipulation of enhancers is critical to complete our understanding of gene regulation;
in the case of CFTR, this knowledge will provide valuable insights into the pathology
and treatment of the life-threatening Mendelian genetic disease Cystic Fibrosis (CF).
Enhancers are associated with a number of biochemical markers of gene structure and
function, such as chromatin modifications and transcription factor binding; however,
leveraging this knowledge to predict the cell-type-specific enhancers affecting CFTR
or other genes of interest requires the integration of massive amounts of data.
We successfully integrated a set of published tools—the Integrative and Discriminative Epigenome Annotation System (IDEAS), the Gapped K-Mer Support
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Vector Machine (gkm-SVM), and DeltaSVM—into a machine learning pipeline. We
use the pipeline to generate unsupervised and cell-type-specific segmentations of the
genome, identify those segments predicted to be enhancers, recognize and score them
based on their DNA sequence characteristics, and then use the sequence-based scores
to assess DNA variants’ potential to modulate enhancer function. Our analysis adds
31 whole-genome epigenetic datasets to the published IDEAS data in order to generate segmentations for key epithelial cells lines used to study CFTR biology: A549,
Caco-2, Calu-3, and PANC-1; this resulted in improvements to previously-existing
segmentations in addition to the generation of new data. We demonstrated the segmentation models’ cell-type specificity and recapitulation of experimentally-measured
in-vitro CFTR expression. We identified a subset of regions within the CFTR topologically associating domain (TAD) that are highly likely, per our models, to demonstrate enhancer activity. Based on the enhancer sequence characteristics we modeled
throughout the genome, we scored observed human DNA variants based on their
likelihood to strengthen or weaken patterns enhancer-signifying sequence motifs.
Our extensive optimization of the sequence-based gkm-SVM classifier revealed
that, though the off-the-shelf implementations and default parameters are quite robust and highly likely to lead to informative sequence-based scores, a small amount of
optimization is possible and leads to a measurable improvement in the characteristics
of the resulting DeltaSVM variant scores. Since improvements appeared to translate
across cell-type-specific models, we have cause to recommend using a slightly adjusted
set of LSGKM parameters in order to model enhancers (word length, L = 10; informative positions, K = 6; allowed mismatches D = 3; estimated L-mer with truncated
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filter and radial basis function kernel; misclassification cost, C = 10; and radial basis
width, γ = 4). We expect, for example, 99.996% of the resulting DeltaSVM scores
to be informative with regard to a given variant’s effect on enhancer function when
the area under the receiver operating characteristic curve for the gkm-SVM classifier
is 0.9042, as was the case for the A549 enhancer model.
We used the gkm-SVM scores of genomic regions near CFTR and the DeltaSVM
scores of variants occurring in and near CFTR to generate a number of observations
and hypothesis regarding regulation of CFTR transcription, which we will use to guide
future demonstrative research. With DeltaSVM and other criteria, we created a shortlist of 119 high-interest variants that we hypothesize are likely to increase or decrease
enhancer function around CFTR; these variants show positional clustering within the
TAD, are often (but not always) present in the population at low allele frequencies,
and are located in regions predicted by IDEAS to have gene-regulatory function. Our
results are largely cell-type specific, which increases our confidence in our predictions
given CFTR’s highly cell-type-specific expression. Finally, we observed the curious
signal of a minority of high-DeltaSVM-scoring variants among variants known to cause
Cystic Fibrosis, and plan further in-depth study to assess the plausibility of CFTRdamaging mutations that also intrinsically alter the enhancer-regulated expression of
the gene in addition to their direct effects on the protein.
Our results will guide critical research to help further elucidate the interwoven
networks of CFTR regulation. A detailed understanding of the cellular pathways
that regulate its expression may allow researchers to identify new CF-causing variants, understand the impact of regulatory variants that may worsen or ameliorate
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CF phenotypes, or identify additional regulatory networks involved in the significant
decrease of CFTR expression from fetal to adult tissue. Given the advent of drugs
that act directly upon the CFTR protein, a deeper understanding of these various
mechanisms may allow the targeted discovery of additional drugs and methods to
complement this activity by increasing the cells’ total output of CFTR that the potentiator and corrector compounds can rescue. As our research demonstrates, the
construction, expansion, and optimization of machine learning tools are critical to
the synthesis of novel biological insights from the massive and continually-growing
amount of genetic and epigenetic data available to modern biology.
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Table A.1: ENCODE BAM List: Filenames & Accession IDs
Filename

ENCODE Accession

ENCFF000AHG A549 CTCF-human b1 t1 hg19.bam
ENCFF000AHI A549 CTCF-human b1 t2 hg19.bam
ENCFF000AHL A549 CTCF-human b1 t1 hg19.bam
ENCFF000AHO A549 CTCF-human b1 t2 hg19.bam
ENCFF000AIE A549 H3K4me1-human b1 t1 hg19.bam
ENCFF000AIG A549 H3K4me1-human b1 t2 hg19.bam
ENCFF000AIM A549 H3K4me1-human b1 t2 hg19.bam
ENCFF000AIN A549 H3K4me1-human b1 t1 hg19.bam
ENCFF000AIP A549 H3K4me2-human b1 t1 hg19.bam
ENCFF000AIQ A549 H3K4me2-human b1 t2 hg19.bam
ENCFF000AIV A549 H3K4me2-human b1 t1 hg19.bam
ENCFF000AIY A549 H3K4me2-human b1 t2 hg19.bam
ENCFF000AJO A549 H3K9ac-human b1 t2 hg19.bam
ENCFF000AJR A549 H3K9ac-human b1 t1 hg19.bam
ENCFF000AKN A549 H3K27me3-human b1 t1 hg19.bam
ENCFF000AKO A549 H3K27me3-human b1 t2 hg19.bam
ENCFF000AKU A549 H3K27me3-human b1 t2 hg19.bam
ENCFF000AKY A549 H3K27me3-human b1 t1 hg19.bam
ENCFF000AKZ A549 H3K36me3-human b1 t1 hg19.bam
ENCFF000ALB A549 H3K36me3-human b1 t2 hg19.bam
ENCFF000ALE A549 H3K36me3-human b1 t2 hg19.bam
ENCFF000ALG A549 H3K36me3-human b1 t1 hg19.bam
ENCFF000ALX A549 H4K20me1-human b1 t2 hg19.bam
ENCFF000ALZ A549 H4K20me1-human b1 t1 hg19.bam
ENCFF000AHA A549 Control-human b2 t1 hg19 f185.bam
ENCFF000AHB A549 Control-human b1 t1 hg19 f190.bam
ENCFF000AHC A549 Control-human b2 t1 hg19 f190.bam
ENCFF000AHD A549 Control-human b1 t1 hg19 f205.bam
ENCFF000AJD A549 H3K4me3-human b1 t1 hg19 f195.bam
ENCFF000AJF A549 H3K4me3-human b2 t1 hg19 f200.bam
ENCFF000AJK A549 H3K4me3-human b1 t1 hg19 f220.bam
ENCFF000AJL A549 H3K4me3-human b2 t1 hg19 f205.bam
ENCFF000AKB A549 H3K27ac-human b2 t1 hg19 f245.bam
ENCFF000AKD A549 H3K27ac-human b1 t1 hg19 f240.bam
ENCFF000AKF A549 H3K27ac-human b1 t1 hg19 f245.bam
ENCFF000AKI A549 H3K27ac-human b2 t1 hg19 f280.bam
ENCFF000MXS A549 CTCF-human b2 t1 hg19 f110.bam
ENCFF000MXY A549 CTCF-human b1 t1 hg19 f105.bam
ENCFF000MYA A549 CTCF-human b1 t1 hg19 f135.bam
ENCFF000MYB A549 CTCF-human b2 t1 hg19 f105.bam
ENCFF000NEJ A549 POLR2A-human b1 t1 hg19 f95.bam
ENCFF000NEM A549 POLR2A-human b2 t1 hg19 f60.bam
ENCFF000NER A549 POLR2A-human b1 t1 hg19 f80.bam
ENCFF000NEU A549 POLR2A-human b2 t1 hg19 f60.bam
ENCFF000NFH A549 Control-human b1 t1 hg19 f70.bam
ENCFF000NFJ A549 Control-human b1 t1 hg19 f85.bam
ENCFF000NFP A549 Control-human b1 t1 hg19 f75.bam
ENCFF000NFS A549 Control-human b1 t1 hg19 f70.bam
ENCFF000NFT A549 Control-human b1 t1 hg19 f155.bam
ENCFF000NFV A549 Control-human b2 t1 hg19 f115.bam
ENCFF000NFW A549 Control-human b1 t1 hg19 f70.bam
ENCFF000NFY A549 Control-human b3 t1 hg19 f180.bam
ENCFF000NGE A549 Control-human b1 t1 hg19 f110.bam

ENCFF000AHG
ENCFF000AHI
ENCFF000AHL
ENCFF000AHO
ENCFF000AIE
ENCFF000AIG
ENCFF000AIM
ENCFF000AIN
ENCFF000AIP
ENCFF000AIQ
ENCFF000AIV
ENCFF000AIY
ENCFF000AJO
ENCFF000AJR
ENCFF000AKN
ENCFF000AKO
ENCFF000AKU
ENCFF000AKY
ENCFF000AKZ
ENCFF000ALB
ENCFF000ALE
ENCFF000ALG
ENCFF000ALX
ENCFF000ALZ
ENCFF000AHA
ENCFF000AHB
ENCFF000AHC
ENCFF000AHD
ENCFF000AJD
ENCFF000AJF
ENCFF000AJK
ENCFF000AJL
ENCFF000AKB
ENCFF000AKD
ENCFF000AKF
ENCFF000AKI
ENCFF000MXS
ENCFF000MXY
ENCFF000MYA
ENCFF000MYB
ENCFF000NEJ
ENCFF000NEM
ENCFF000NER
ENCFF000NEU
ENCFF000NFH
ENCFF000NFJ
ENCFF000NFP
ENCFF000NFS
ENCFF000NFT
ENCFF000NFV
ENCFF000NFW
ENCFF000NFY
ENCFF000NGE
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Table A.2: ENCODE BAM List: Filenames & Accession IDs, Continued
Filename

ENCODE Accession

ENCFF000QTF Panc1 Control-human b2 t1 hg19 f85.bam
ENCFF000QTH Panc1 Control-human b1 t1 hg19 f80.bam
ENCFF000QTK Panc1 Control-human b1 t1 hg19 f115.bam
ENCFF000QTM Panc1 Control-human b2 t1 hg19 f90.bam
ENCFF000QTO Panc1 Control-human b1 t1 hg19 f65.bam
ENCFF000RLW A549 CTCF-human b1 t1 hg19 f105.bam
ENCFF000RLY A549 CTCF-human b2 t1 hg19 f105.bam
ENCFF000RMA A549 Control-human b t hg19 f100.bam
ENCFF000RME A549 POLR2A-human b1 t1 hg19 f105.bam
ENCFF000RMG A549 POLR2A-human b2 t1 hg19 f110.bam
ENCFF000SEG A549 DNase-seq b1 t1 hg19 f0.bam
ENCFF000SEJ A549 DNase-seq b2 t1 hg19 f0.bam
ENCFF000TGC A549 FAIRE-seq b1 t1 hg19 f80.bam
ENCFF000TGE A549 FAIRE-seq b2 t1 hg19 f90.bam
ENCFF000VIN Panc1 H3K4me1-human b1 t1 hg19 f185.bam
ENCFF000VIO Panc1 H3K4me1-human b2 t1 hg19 f230.bam
ENCFF000VJA Panc1 H3K4me3-human b2 t1 hg19 f210.bam
ENCFF000VJB Panc1 H3K4me3-human b1 t1 hg19 f220.bam
ENCFF000VJE Panc1 H3K27ac-human b2 t1 hg19 f245.bam
ENCFF000VJG Panc1 H3K27ac-human b1 t1 hg19 f195.bam
ENCFF000VJN Panc1 Control-human b1 t1 hg19 f405.bam
ENCFF000VPA A549 CTCF-human b1 t1 hg19 f120.bam
ENCFF000VPO A549 CTCF-human b2 t1 hg19 f125.bam
ENCFF001ARO A549 DNase-seq b1 t hg19 f50.bam
ENCFF001CLE A549 DNase-seq b1 t1 hg19 f50.bam
ENCFF001CLJ A549 DNase-seq b2 t1 hg19 f50.bam
ENCFF001COS Caco-2 DNase-seq b1 t1 hg19 f105.bam
ENCFF001COY Caco-2 DNase-seq b2 t1 hg19 f90.bam
ENCFF001EDO Panc1 DNase-seq b1 t1 hg19 f90.bam
ENCFF001EDP Panc1 DNase-seq b2 t1 hg19 f90.bam
ENCFF001ELO A549 H3K4me3-human b1 t1 hg19 f180.bam
ENCFF001ELP A549 H3K4me3-human b2 t1 hg19 f185.bam
ENCFF001ERU Caco-2 H3K27me3-human b1 t1 hg19 f120.bam
ENCFF001ERZ Caco-2 H3K27me3-human b2 t1 hg19 f120.bam
ENCFF001ESD Caco-2 H3K36me3-human b1 t1 hg19 f115.bam
ENCFF001ESE Caco-2 H3K36me3-human b2 t1 hg19 f115.bam
ENCFF001ESO Caco-2 H3K4me3-human b1 t1 hg19 f150.bam
ENCFF001EST Caco-2 H3K4me3-human b2 t1 hg19 f150.bam
ENCFF001GBD Panc1 H3K4me3-human b1 t1 hg19 f180.bam
ENCFF001GBK Panc1 H3K4me3-human b2 t1 hg19 f190.bam
ENCFF001GVI A549 CTCF-human b1 t1 hg19 f210.bam
ENCFF001GVJ A549 CTCF-human b2 t1 hg19 f130.bam
ENCFF001GVS A549 Control-human b1 t1 hg19 f155.bam
ENCFF001GZV Caco-2 CTCF-human b1 t1 hg19 f110.bam
ENCFF001HAC Caco-2 CTCF-human b2 t1 hg19 f100.bam
ENCFF001HAF Caco-2 Control-human b1 t1 hg19 f85.bam
ENCFF001HVY Panc1 Control-human b1 t1 hg19 f155.bam
ENCFF321TUP A549 Control-human b1 t hg19 f195.bam
ENCFF425JYG A549 Control-human b2 t hg19 f120.bam
ENCFF652DOI Caco-2 DNase-seq b2 t hg19 f90.bam
ENCFF806YIH A549 Control-human b2 t hg19 101readlen f200.bam
ENCFF863STQ A549 Control-human b1 t hg19 f105.bam
ENCFF931PPM Caco-2 DNase-seq b1 t hg19 f105.bam

ENCFF000QTF
ENCFF000QTH
ENCFF000QTK
ENCFF000QTM
ENCFF000QTO
ENCFF000RLW
ENCFF000RLY
ENCFF000RMA
ENCFF000RME
ENCFF000RMG
ENCFF000SEG
ENCFF000SEJ
ENCFF000TGC
ENCFF000TGE
ENCFF000VIN
ENCFF000VIO
ENCFF000VJA
ENCFF000VJB
ENCFF000VJE
ENCFF000VJG
ENCFF000VJN
ENCFF000VPA
ENCFF000VPO
ENCFF001ARO
ENCFF001CLE
ENCFF001CLJ
ENCFF001COS
ENCFF001COY
ENCFF001EDO
ENCFF001EDP
ENCFF001ELO
ENCFF001ELP
ENCFF001ERU
ENCFF001ERZ
ENCFF001ESD
ENCFF001ESE
ENCFF001ESO
ENCFF001EST
ENCFF001GBD
ENCFF001GBK
ENCFF001GVI
ENCFF001GVJ
ENCFF001GVS
ENCFF001GZV
ENCFF001HAC
ENCFF001HAF
ENCFF001HVY
ENCFF321TUP
ENCFF425JYG
ENCFF652DOI
ENCFF806YIH
ENCFF863STQ
ENCFF931PPM
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Table A.3: ENCODE BigWig Tracks (Wiggler Project)
Filename
wgEncodeBroadHistoneGm12878H3k4me1StdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneGm12878H3k4me2StdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneGm12878H3k4me3StdAln 4Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneGm12878H3k9acStdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneGm12878H3k27acStdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneGm12878H3k27me3StdAln 4Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneGm12878H3k36me3StdAln 4Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneGm12878H4k20me1StdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsGm12878Pol2Std 9Reps.norm5.rawsignal.bw
wgEncodeAllLabsGm12878CtcfStd 9Reps.norm5.rawsignal.bw
wgEncodeOpenChromDnaseGm12878Aln 5Reps.norm5.rawsignal.bw
wgEncodeUwDnaseGm12878Aln 2Reps.norm5.rawsignal.bw
wgEncodeOpenChromFaireGm12878Aln 3Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneGm12878ControlStdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneH1hescH3k4me1StdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneH1hescH3k4me2StdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneH1hescH3k4me3StdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneH1hescH3k9acStdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneH1hescH3k27acStdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneH1hescH3k27me3StdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneH1hescH3k36me3StdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneH1hescH4k20me1StdAln 2Reps.norm5.rawsignal.bw
wgEncodeHaibTfbsH1hescPol2Pcr1xAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsH1hescCtcfStd 5Reps.norm5.rawsignal.bw
wgEncodeOpenChromDnaseH1hescAln 2Reps.norm5.rawsignal.bw
wgEncodeUwDnaseH1hescAln 1Reps.norm5.rawsignal.bw
wgEncodeOpenChromFaireH1hescAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneH1hescControlStdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHelas3H3k4me1Std 1Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHelas3H3k4me2StdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneHelas3H3k4me3StdAln 4Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHelas3H3k9acStdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHelas3H3k27acStdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneHelas3H3k27me3StdAln 4Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneHelas3H3k36me3StdAln 4Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHelas3H4k20me1StdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsHelas3Pol2Std 5Reps.norm5.rawsignal.bw
wgEncodeAllLabsHelas3CtcfStd 6Reps.norm5.rawsignal.bw
wgEncodeOpenChromDnaseHelas3Aln 3Reps.norm5.rawsignal.bw
wgEncodeUwDnaseHelas3Aln 2Reps.norm5.rawsignal.bw
wgEncodeOpenChromFaireHelas3Aln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHelas3ControlStdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHepg2H3k4me1Std 1Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHepg2H3k4me2StdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneHepg2H3k4me3StdAln 4Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHepg2H3k9acStdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHepg2H3k27acStdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneHepg2H3k27me3StdAln 4Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneHepg2H3k36me3StdAln 4Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHepg2H4k20me1StdAln 2Reps.norm5.rawsignal.bw
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Table A.4: ENCODE BigWig Tracks (Wiggler Project) Continued
Filename
wgEncodeAllLabsHepg2Pol2Std 4Reps.norm5.rawsignal.bw
wgEncodeAllLabsHepg2CtcfStd 8Reps.norm5.rawsignal.bw
wgEncodeOpenChromDnaseHepg2Aln 3Reps.norm5.rawsignal.bw
wgEncodeUwDnaseHepg2Aln 2Reps.norm5.rawsignal.bw
wgEncodeOpenChromFaireHepg2Aln 3Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHepg2ControlStdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHuvecH3k4me1StdAln 3Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHuvecH3k4me2StdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneHuvecH3k4me3StdAln 5Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHuvecH3k9acStdAln 3Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHuvecH3k27acStdAln 3Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneHuvecH3k27me3StdAln 4Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneHuvecH3k36me3StdAln 5Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHuvecH4k20me1StdAln 3Reps.norm5.rawsignal.bw
wgEncodeAllLabsHuvecPol2Std 5Reps.norm5.rawsignal.bw
wgEncodeAllLabsHuvecCtcfStd 7Reps.norm5.rawsignal.bw
wgEncodeOpenChromDnaseHuvecAln 2Reps.norm5.rawsignal.bw
wgEncodeUwDnaseHuvecAln 2Reps.norm5.rawsignal.bw
wgEncodeOpenChromFaireHuvecAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneHuvecControlStdAln 3Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneK562H3k4me1StdAln 4Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneK562H3k4me2StdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneK562H3k4me3StdAln 6Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneK562H3k9acStdAln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneK562H3k27acStdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneK562H3k27me3StdAln 6Reps.norm5.rawsignal.bw
wgEncodeAllLabsHistoneK562H3k36me3StdAln 4Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneK562H4k20me1StdAln 2Reps.norm5.rawsignal.bw
wgEncodeAllLabsK562Pol2Std 6Reps.norm5.rawsignal.bw
wgEncodeAllLabsK562CtcfStd 7Reps.norm5.rawsignal.bw
wgEncodeOpenChromDnaseK562Aln 2Reps.norm5.rawsignal.bw
wgEncodeUwDnaseK562Aln 2Reps.norm5.rawsignal.bw
wgEncodeOpenChromFaireK562Aln 2Reps.norm5.rawsignal.bw
wgEncodeBroadHistoneK562ControlStdAln 1Reps.norm5.rawsignal.bw

Table A.5: NCBI GEO SRA Filenames & Accession IDs
Filename

Description

NCBI GEO Accession

SRR1655063.sra
SRR1655064.sra
SRR1655065.sra
GSM1548076 Calu3 DHS.bed

Calu3
Calu3
Calu3
Calu3

GSM1548073
GSM1548074
GSM1548075
GSM1548076

ChIP-seq Control
H3K4me1
H3K27ac
DHS
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Table A.6: Pre-Publication Data Filenames & Accession IDs
Filename

Description

AH214.fasta
AH278.fasta

Calu3 H3K4me3
Calu3 H3K36me3
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